Western Michigan University

ScholarWorks at WMU
Dissertations

Graduate College

12-1999

Comparing Outcome o f Residential and Intensive Outpatient
Treatment Services for Substance Dependence
Shawn E. Channell
Western Michigan University

Follow this and additional works at: https://scholarworks.wmich.edu/dissertations
Part of the Psychology Commons, and the Substance Abuse and Addiction Commons

Recommended Citation
Channell, Shawn E., "Comparing Outcome o f Residential and Intensive Outpatient Treatment Services for
Substance Dependence" (1999). Dissertations. 1497.
https://scholarworks.wmich.edu/dissertations/1497

This Dissertation-Open Access is brought to you for free
and open access by the Graduate College at
ScholarWorks at WMU. It has been accepted for inclusion
in Dissertations by an authorized administrator of
ScholarWorks at WMU. For more information, please
contact wmu-scholarworks@wmich.edu.

COMPARING OUTCOME OF RESIDENTIAL AND INTENSIVE
OUTPATIENT TREATMENT SERVICES
FOR SUBSTANCE DEPENDENCE

by
Shawn E. Channell

A Dissertation
Submitted to the
Faculty o f The Graduate College
in partial fulfillment o f the
requirements for the
Degree o f Doctor o f Philosophy
Department of Psychology

Western Michigan University
Kalamazoo, Michigan
December 1999

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

COMPARING OUTCOME OF RESIDENTIAL AND INTENSIVE
OUTPATIENT TREATMENT SERVICES
FOR SUBSTANCE DEPENDENCE

Shawn E. Channell, Ph.D.
Western Michigan University, 1999

The past 20 years have witnessed a significant increase in the number o f published
studies comparing inpatient with outpatient substance dependence treatment The
majority o f these studies have reported no benefit for those recipients receiving more
intensive treatment However, the outpatient treatment investigated in these studies has
typically been day treatment often involving 27 hours a week o f participation, and not
intensive outpatient treatment (IOP), which involves 12 or fewer hours o f participation
per week. Additionally, few published studies have compared alcohol and cocaine
dependent populations.

This study was designed to compare effectiveness o f the

residential and intensive outpatient levels o f treatment for both alcohol and cocaine
dependent populations.
Forty-eight participants were randomly selected from a total pool o f 132 eligible
participants and assigned to one o f four groups: (1) alcohol dependent in residential
treatment; (2) alcohol dependent in IOP treatment; (3) cocaine dependent in residential
treatment; and, (4) cocaine dependent in IOP treatment.
The groups were compared at intake, 10 days, 30 days, and 60 days after entering
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treatment on the following variables: drug/alcohol use, employment status, denial, 12
step participation, relapse prevention skills, medical status, psychiatric status, and social
support. Data was gathered from four scales o f the Addiction Severity Index (McLellan
et al., 1980), as well as an assessment developed by the author.
Results indicate that both residential and IOP treatments are effective in reducing
problems related to drug and alcohol use, as well as improving employment status, denial,
12 step participation, relapse prevention skills, and psychiatric status.

However,

improvement did not occur in the areas o f medical status o r social support for either
group. There were few significant differences between the residential and IOP groups in
areas o f improvement. Additionally, significant differences were not apparent between
the alcohol and cocaine dependent groups. Relapse rates were similar for all groups.
Overall, the results support the use of IOP treatment as a viable alternative to residential
treatment for alcohol dependent and cocaine dependent patients at a cost o f roughly onethird that o f residential placement
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INTRODUCTION

Drug Abuse and Dependence in the 1990s

Data obtained as part o f the Epidemiological Catchement Area Study o f the
National Institute o f Mental Health indicate that nearly 20% o f the general population o f
the United States (approximately 48 million people) meet criteria for substance
dependence or abuse at some point in their life (Regier et. al., 1990).

An economic

analysis of addictions treatment prepared for the President’s Commission on Model State
Drug Laws (Langenbucher, McCrady, Brick, & Esterly, 1993) estimated that the cost o f
substance dependence and abuse to U.S. Society, both for direct services to the individual
and services to the family, lies between $150 billion and $200 billion annually.
The use o f drugs and alcohol have been described in numerous ways, including
both clinical and popular culture terms. Among the more socially acceptable popular
terms are “addict” and “alcoholic.” However, these terms lack formal definitions and will
therefore not be utilized in the following discussion. Rather, the terms “substance
dependence” (e.g., alcohol dependence, cocaine dependence) and “substance abuse” (e.g.,
alcohol abuse and cocaine abuse) will be utilized with diagnostic criteria selected from the

Diagnostic and StatisticalM anual (DSM-IV\ 1994) as defining factors. DSM-IV defines
“substance dependence” as follows:
. . . a cluster of cognitive, behavioral, and physiological symptoms indicating that
the individual continues use o f the substance despite significant substance-related
1
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problems. There is a pattern o f repeated self-administration th at usually results
in tolerance, withdrawal, and compulsive drug taking behavior (p. 176).
“Substance abuse” is defined as follows:
. . . a maladaptive pattern o f substance use manifested by recurrent and significant
adverse consequences related to the repeated use o f substances . . . Unlike the
criteria for Substance Dependence, the criteria for Substance Abuse do not
include tolerance, withdrawal, o r a pattern o f compulsive use and instead include
only the harmful consequences o f repeated use (p. 182).
For more than 20 years the United States has attempted to deal w ith the problems
o f substance abuse and dependence through what has commonly been referred to as “The
War on Drugs.” This “war” has focused primarily on combating drug addiction and abuse
by concentrating on stopping the flow o f illegal drugs and punishing th e user rather than
focusing on drug abuse prevention, education, or addiction treatment (Firshein, 1998).
Only one third o f the billions of dollars the federal government spends fighting substance
addiction is targeted at prevention and treatment; two thirds continue to be devoted to
law enforcement and interdiction o f drugs (Baum, 1996; Firshein, 1998). This statistic
may in fact be lower, according to Neegaard (1998), the nation spends only 20% o f its
$17 billion drug-control budget to treat those individuals dependent o n substances.
Every dollar spent on substance abuse treatment is estimated to produce at least
seven dollars worth o f savings in terms o f healthcare costs, increased productivity, and
reductions in accidents (Firshein, 1998; Neergaard, 1998). The 1996 President's
Commission on Model State Drug Laws found that about 65 percent o f all emergency
hospital visits in the U.S. are alcohol- and drug-related. Following treatment, according
to Firshein, absenteeism, disability days, and disciplinary actions in th e workplace drop
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by fifty-percent. A RAND Corporation study found that providing treatment to all
addicts in the U.S., at a price tag o f $21 billion, would save more than $150 billion in
social costs over the next 15 years, a sevenfold return on investment (Firshein, 1998).
The data cited above clearly indicate the importance o f an increased focus on
treatment for substance dependence and abuse in this country. One area o f research
requiring urgent attention is identifying which types o f treatment are most effective at the
overall lowest cost to society. This becomes especially important in a society where the
current Zeitgeist is prosecution and not rehabilitation. There are currently a wide variety
o f treatment modalities available, with an equally wide range of treatment costs.
An examination o f the modem history of substance dependence treatment reveals
that until the mid-1970s the model for substance dependence treatment remained fairly
uniform:

28-day residential/inpatient treatment focused on individual therapy,

psychoeducational information, relapse prevention, and an introduction to 12-Step
recovery programs (Rotgers, Keller, & Morgenstem, 1996). As controlled research on
the outcome o f substance dependence treatment has increased, a trend has begun to
emerge which indicates that traditional substance dependence treatment, while beneficial
for some, may have little long-term benefit (Rotgers, Keller, & Morgenstem, 1996).
Research evidence, coupled with an overall trend to contain the cost o f treatment
brought about by managed care, have contributed to the significant change in the way
substance dependence treatment is currently offered. Perhaps the most noticeable change
has been a shortening o f the average length o f stay to two weeks o r less (McKay,
Cacciola, McLellan, Alterman, & Wirtz, 1997). For example, Rotgers, Keller, and
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Morgenstem (1996), discussing a treatment facility with which one of the authors was
affiliated, point to a drop in the length o f an inpatient stay from 19 to 11 days between
1993 and 1994, almost a 50% decrease within the space o f one year.
As the field of substance dependence treatment changes, and the importance o f
effective substance dependence treatment increases, the need fo r research investigating
what works in treatment and what does not also increases in importance. The National
Center on Addiction and Substance Abuse at Columbia University specifically points out
the need for increased research that will tell us what works in prevention and treatment,
for whom, and at what cost. Given the tremendous cost o f substance dependence and
abuse treatment and management, greater investment in evaluating treatment may yield
greater benefits in reducing cost (CASA, 1996).
To successfully evaluate and/or conduct research in the field o f substance
dependence it is important that there is an understanding of the methods utilized to place
individuals in treatment, as well as the treatment outcome literature comparing more
traditional inpatient treatment with contemporary outpatient treatment

Levels o f Care in Substance Dependence Treatment

The American Society o f Addiction Medicine (ASAM) Patient Placement Criteria
- Second Edition (1996) identify five levels o f service ranging from early intervention
through outpatient services to medically-managed intensive inpatient care. The levels o f
service described in the criteria are:
Level 0.5:

Early Intervention
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Level I:

Outpatient Services

Level II:

Intensive Outpatient/Partial Hospitalization Services

Level III:

Residential/Inpatient Services

Level IV:

Medically-Managed Intensive Inpatient Services.

The level of treatment indicated for each individual is identified by assessing the
following problem areas:
1. Acute intoxication and/or withdrawal potential.
2. Biomedical conditions and complications.
3.

Emotional/behavioral conditions and complications (e.g., psychiatric

conditions, psychological, or emotional/behavioral complications o f known or unknown
origin, poor impulse control, changes in mental status, o r transient neuropsychiatric
complications).
4. Treatment acceptance/resistance.
5. Relapse/continued use potential.
6. Recovery/living environment.
At the level o f Early Intervention (Level 0.5), the least intensive of the four levels,
the individual may experience problems related to substance use, but does not meet
criteria for Substance-Related Disorder, as indicated by DSM -IV (1994). Typically
treatment at the early intervention stage will be minimal and psychoeducational in nature.
Often treatment at this level will focus on prevention.
Outpatient Services (Level I) provide less than nine hours per week o f structured
programming. Intensive Outpatient Services (IOP, Level II. 1) provide nine or more
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hours o f structured programming per week. Partial Hospitalization or Day Treatment
(Level II.5) provides 20 o r more hours o f clinically intensive programming per week.
Residential (Level ULi) and Inpatient (Level IIL3) provide organized services staffed by
addiction treatment personnel who provide a planned regimen o f patient care in a 24-hour
live-in setting. Medically Managed Inpatient Services (Level IV) provide inpatient
services to those individuals who are experiencing significant medical complications.

Comparison o f Outcome o f Inpatient and Outpatient Treatment Programs

It is well established that inpatient and residential care are the most expensive o f
the various types o f substance dependence treatments available (McLellan et al., 1997;
Rogers et al., 1996). Neergaard (1998) points out that the costs o f individual residential
drug treatm ent programs range from $4,400 to $6,800 a year, whereas traditional
outpatient treatment costs approximately $1,800 and intensive outpatient $2,500.
It had been assumed for many years that more intensive, and therefore more
expensive, treatment was also the most effective. Washton (1997) states, for example,
that in the 1970s and early 1980s it was:
the prevailing altitude among many workers in the field and among the public at
large that addicts must be removed from their drug-using environment (and
preferably for a very long time) in order to be meaningfully rehabilitated.
Outpatient treatment was seen as a poor alternative to extended residential care
(p. xxii).
However, as treatment studies began examining different levels o f treatment,
evidence began to emerge that perhaps this long-standing assumption was incorrect. One
of the earliest comparison studies was conducted by McClachlan and Stein in 1982. The
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authors compared outcome, at one year post-treatment, o f 100 alcohol dependent patients
randomly assigned to a four-week program in either inpatient or partial day treatment.
The authors found that the groups did not differ on outcome measures o f alcohol use,
mental, medical or legal status.
In 1983 the Congressional Office o f Technology Assessment (Saxe, Dougherty,
Esty & Fine, 1983), likely spurred on by the outcome o f studies like that conducted by
McClachlan and Stein (1982), released a report which reviewed the existing research
comparing inpatient and day treatment for alcohol abuse and/or dependence. The report
stated that there was substantial evidence that indicated less costly outpatient treatment
was as effective as more costly inpatient care.
Three years later, Miller and Hester (1986) conducted a meta-analysis and
generated the following conclusion:
26 controlled comparisons have consistently shown no overall advantage for
residential over non-residential settings, for longer over shorter inpatient
programs, or for more intensive over less intensive interventions in treating
alcohol abuse (p. 794).
Harrison, Hoffman, Gibbs, Hollister and Luxenberg (1988) investigated the
efficacy o f inpatient and intensive outpatient treatment for 319 alcohol dependent patients.
These authors found, like Miller and Hester, no significant differences between intensive
and less intensive treatment settings.
In 1988 the Congressional Office o f Technology Assessment (Saxe & Goodman,
1988) updated its findings with a study focusing on controlled research. The results o f
this study reaffirmed the findings from the 1983 study that there is no evidence that
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inpatient treatment is more effective than outpatient treatment.
All o f the studies discussed thus far have focused on treatment for alcohol abuse
or alcohol dependence. Results of research investigating treatment outcome o f cocaine
dependent individuals have been less conclusive, but have largely supported the concept
that there is little advantage o f residential treatment over outpatient treatment.
Alterman et al. (1994), for example, compared the effectiveness and costs o f day
treatment and inpatient rehabilitation for 111 cocaine dependent individuals. The authors
found that a significantly greater proportion o f inpatient subjects completed treatment
than did outpatient subjects. However, consistent with data from the alcohol dependence
literature, they found little evidence of differential improvement between groups despite
the fact that completion o f day treatment cost 39% less than completing inpatient
treatment
Schneider, Mittelmeier, and Gadish (1996) investigated day treatment and
inpatient treatment for 75 cocaine dependent patients. The authors followed up at both
three months and six months post-treatment. At three months the subjects having
received inpatient treatment had a statistically significant higher rate o f abstinence;
however, this difference had disappeared by six months. Based on these results the
authors conclude that day treatment is a viable alternative to inpatient treatment over the
long term.
McKay, Alterman, McLellan, and Snider (1994) investigated the outcome o f a day
treatment program for both cocaine and alcohol dependence. The authors focused
primarily on the relationship between day hospital treatment goals, self-help group
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participation, and substance use outcome for 180 male subjects. Results indicated a better
outcome for those clients completing day treatment and participating in a self-help group.
Significant differences were not found between cocaine dependent and alcohol dependent
subjects with regard to outcome. This sample was restricted to male veterans, 82% o f
which were African-American with low socio-economic status.
Walsh et al. (1991) conducted one o f the few studies indicating that outpatient
services are not as effective as inpatient services. The authors found that cocaine abusers
assigned to inpatient treatment were more likely to have better outcomes than cocaine
abusers sent to Alcoholics Anonymous or given their choice o f treatm ent These results
suggest that inpatient treatment may improve outcome when compared with AA o r the
client’s choice o f placement. However, it is important to recognize that Walsh et al.
compared inpatient placement only to basic outpatient treatment or self-help group
attendance, and did not investigate intensive outpatient services.
Overall, research results bring into question the effectiveness of residential
treatment and other intensive treatment modalities when contrasted with less intensive,
and less expensive, services. However, McLellan et al. (1997) make the point that “it is
possible to criticize all o f these studies on methodological, clinical, and practical grounds”
(p. 59). Unfortunately, it is true that there are a number o f areas which reduce the ability
to draw firm conclusions from these studies.
For example, there are fewer studies investigating cocaine dependence than there
are investigating alcohol dependence. A likely reason for this is the relative recency o f
broad cocaine use, in relation to a long history o f problems related to alcohol use. W hile
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both diagnoses are instances o f “substance dependence/’ they differ with regard to
physiological and sociological factors. These differences may contribute to differences
in the recovery process as well.
Available research has primarily compared inpatient treatment with day treatment
or strict outpatient placement. While day treatment is less intensive than inpatient
treatment, it is often substantially more intensive than IOP treatment However, there has
been little research investigating IOP treatment The paucity o f research investigating
intensive outpatient substance dependence treatment is alarm ing given the fact that the
modality is being utilized with increasing regularity (Campbell, Gabrielli, Laster, &
Liskow, 1997).
The effects o f managed care have also served to significantly reduce the standard
length o f stay utilized in residential placement Many o f the published studies available
investigating residential treatment have utilized a 28-day length o f stay, much more than
the 10 day or less length o f stay which is very prevalent in many treatment centers
presently. Clinical research has had difficulty keeping up with the rapidly reducing length
o f stay.
Additionally, many of the studies in the published literature are conducted at
university medical centers or Veteran’s Administration Medical Centers. Gottheil,
Sterling and Weinstein (1995) point out that though these settings may have numerous
resources, abundant well-trained staff, and utilize strict criteria for determining which
patients to include in the study, they are also likely to be very different from the more
typical, often publicly funded, treatment clinics. Additionally, the populations investigated
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in these studies are typically fairly homogeneous with regard to variables such as race
and gender. These differences may significantly affect the generalizability o f these
studies to other populations.
Each o f these limitations will be discussed below.

Limitations o f Previous Research

Minimal Comparisons o f Cocaine and Alcohol Dependence

Harrison, Hoffman, Gibbs, Hollister & Luxenberg (1988) point out two
longstanding assumptions in the field o f substance dependence: “ 1) There are no
significant differences between people who drink and people who also use drugs, and
2) there are no significant differences between alcohol abuse and drug abuse (p. 359).”
Although there is some reason to assume that similar treatment outcome results
would be found between cocaine dependent and alcohol dependent individuals, there has
been very little research to support this assumption (Schneider, Mittelmeier, and Gadish,
1996). There are a number o f differences between alcohol and cocaine and their abuse
which could potentially contribute to differing treatment outcomes.

Cocaine

The use o f cocaine for mood altering purposes is not a recent development. On
the contrary, coca leaves (the source o f cocaine) have been chewed for religious,
medicinal, and psychological purposes for at least 15 centuries. Archaeological evidence
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reveals that coca leaves were placed in Peruvian grave sites as early as 500 A.D. (Weiss,
Mirin, and Bartel, 1994).

It was not until 1855 that cocaine was first refined from the

coca leaf and was called, at that time, erythroxyline. It was first termed cocaine in 1859.
By the year 1900, use and experimentation o f the compound was flourishing.
Among the staunchest admirers and proponents of cocaine’s virtues was Sigmund Freud.
Freud referred to cocaine as a “magical drug” and recommended it for numerous
maladies, including anesthesia, pain, depression, low sexual drive, alcoholism, morphine
addiction, and asthma. Freud eventually recanted his ebullience regarding cocaine use,
primarily after realizing its addictive nature.
In 1886 John Styth Pemberton created a new patent medicine to treat “all nervous
infections.” The name o f the new medication was Coca Cola and its primary ingredient
was cocaine. The popularity o f Coca Cola further increased the use o f cocaine in the
United States.

Eventually, Coca Cola substituted caffeine as its active ingredient,

replacing cocaine. However, decocainized coca leaves are still used in Coca Cola (Weiss,
Mirin, and Bartel, 1994).
The use o f cocaine was first restricted in 1914 by the Federal Harrison Narcotics
Act. From this period until the early 1970s cocaine use was not prevalent beyond the
fringe culture, including movie stars, jazz musicians, and wealthy thrill seekers. Legal
reasons played some part in the diminished use of cocaine during this period; however,
the discovery o f amphetamine likely played a larger part (Julien, 1988). Amphetamine
cost less than cocaine and the effects last longer. In the late 1960s, Federal restrictions
on amphetamine distribution raised the cost of amphetamine to such an extent that
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cocaine once again became attractive.
By 1970 cocaine had become the drug for the rich and powerful. In fact, cocaine
received glamorization not seen since nearly a century prior, albeit this time from popular
culture rather than physicians. By 1985, approximately 5.8 million people in the United
States were current users o f cocaine. Although these numbers have declined significantly,
to 1.9 million by 1991, cocaine remains a major public health problem today (Weiss,
Mirin, and Bartel, 1994).
Cocaine is classified as a central nervous system (CNS) stimulant. Primarily, the
compound elevates mood, induces euphoria, increases alertness, reduces fatigue,
decreases appetite, improves task performance and relieves boredom. Pharmacologically,
cocaine has two primary actions. First, it is a potent local anesthetic. Second, it is a
powerful stimulant o f dopamine neurotransmission (Julien, 1988).
There are three primary methods o f ingestion for cocaine, intranasally
(“snorting”), smoking, and injection. Intranasal cocaine use reached its peak in the mid
1980s, with approximately 61% o f cocaine users reporting predominantly intranasal use
in 1983. By 1989 this statistic dropped to approximately 39% (Weiss, Mirin, and Bartel,
1994).
When cocaine is used intranasally it is rapidly absorbed into the bloodstream. The
drug can be detected in the blood within three minutes after use. Blood level o f cocaine
increases quickly and peaks between 15 and 60 minutes following use. The effects o f the
drug on mood are most prominent within 15 minutes after use.

Physical changes,

primarily increased heart rate and blood pressure, occur strongly within 15 to 20 minutes
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and dissipate after about an hour (Weiss, Mirin, and Bartel, 1994).
Following intranasal use o f cocaine, the user may experience anxiety, depression,
fatigue, and irritability. These symptoms are often associated with a desire for more
cocaine, typically as a way to avoid the symptoms themselves.
W hile intranasal use o f cocaine has decreased over the past several years, the
change has been more than made up for by an increase in the number o f people smoking
cocaine. Without question this increase can be attributed to the introduction of “crack”
cocaine to the United States in 1985. Users o f crack tend to be younger than those who
use cocaine intranasally, and are also more likely to use other illicit drugs (Smart, 1991).
Prior to 1985, smoking cocaine was popular in the form o f “freebasing,”
introduced in 1974. Freebase is made by combining cocaine hydrochloride with ammonia
and ether. The process is very dangerous due to the use o f volatile substances and high
heat in order to extract the cocaine base. Crack cocaine is made by combining cocaine
hydrochloride with water and sodium bicarbonate, resulting in an alkaline precipitate o f
cocaine. This method is easier, and safer, than preparing cocaine freebase.
The smoking of crack causes a very rapid increase in the blood level of cocaine
and, in contrast to intranasal use, results in near instantaneous psychological effects which
peak at approximately five minutes. Euphoria is typically the emotional experience and
occurs almost immediately, accompanied by physiological effects such as a rise in blood
pressure, pulse, body temperature and respiratory rate (Weiss, Mirin, and Bartel, 1994).
The euphoria dissipates 10 to 20 minutes after inhalation. Many crack cocaine users
describe feelings of anxiety and depression following drug use. These feelings are often
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accompanied by an intense craving for more crack. Immediate repetitive use o f cocaine
is more common when smoked than when taken by other methods.
Intravenous cocaine use is the least popular method o f administration. Cocaine
is prepared for intravenous administration by placing between one-tenth and one-quarter
o f a gram in a spoon and adding water. This solution is drawn into a syringe and injected.
Like smoking crack, euphoria occurs almost immediately. Intravenous cocaine use is
highly addictive for the same reasons that smoking cocaine is: intensity o f the emotional
reaction, immediate onset, and the short lasting high. IV cocaine users often report
depression and irritability within five to 15 minutes after use, followed by an intense desire
for more cocaine. It is common for intravenous cocaine users to inject the drug every five
minutes until their supply is exhausted (Weiss, Mirin, & Bartel, 1994).
Gawin and Klaber (1986) investigated intranasal, smokers, and intravenous
cocaine users with regard to their method o f cocaine use. Results indicated that although
both intranasal and intravenous cocaine users used similar amounts o f cocaine in the
course of a week, the intravenous user tended to use very large amounts of cocaine during
discrete, brief periods, whereas the intranasal user used the drug more often but at lower
doses. Cocaine smokers used nearly twice as much cocaine as the other groups, with
longer runs and even heavier drug use than either group.
Cocaine acts as an activator o f the sympathetic nervous system, which controls
functions such as blood pressure, heart rate, heart beat, blood sugar levels, mood, and
appetite (Weiss, Mirin, and Bartel, 1994). By activating the sympathetic nervous system
cocaine initiates responses characteristic o f the fight or flight response, including:
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euphoria, decreased appetite, mental stimulation, rapid heartbeat, increased blood
pressure, elevated body temperature, increased breathing rate, increased rapidity o f
electrical activity in the brain, and elevated blood sugar level.
Specifically, cocaine appears to prevent the reuptake o f dopamine, norepinephrine,
and serotonin into the presynaptic neuron after they have been released into the synapse.
Cocaine may also function as an agonist for dopamine and norepinephrine, causing more
o f these neurotransmitters to be released into the synaptic cleft The increased availability
o f these neurotransmitters is thought to play a significant role in the behavioral and
psychological effects o f cocaine. When cocaine is used chronically, the sensitivity o f
dopamine receptors is altered, thereby resulting in a need for increased neurotransmitters
in order to feel “normal” and even greater numbers to feel “high.” This change in
dopamine receptors has been used to explain the development o f tolerance to cocaine, as
well as withdrawal (Weiss, Mirin, and Bartel, 1994).
A 30% increase o f cocaine related emergencies occurred between 1990 and 1991.
This increase resulted in 25,000 cocaine related emergencies reported in a three-month
period in 1991 (Weiss, Mirin, and Bartel, 1994). In 1989, nearly 2,500 people died o f
cocaine overdose. Drug related complications can occur immediately as the result o f
taking too much o f the drug (i.e., overdose) by way o f heart attack, ventricular
tachycardia or fibrillation, cerebral hemorrhage, heatstroke, seizure, and respiratory
failure. Prolonged drug use can result in chronic nasal problems due to intranasal use,
lung damage due to smoking cocaine, heart damage (cardiomyopathy), vitamin
deficiencies, sexual difficulties and psychological problems (Weiss, Mirin, and Bartel,
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1994). Beyond these primary medical problems, cocaine can cause significant problems
to the fetus during pregnancy if ingested by a pregnant woman. Numerous medical
problems can also occur due to the paraphernalia associated with cocaine use (e.g., dirty
needles, adulterated cocaine).

Alcohol

Alcohol is the only drug with which deliberate self-induced intoxication is socially
acceptable (Julien, 1988). While there are numerous routes o f administration for the
cocaine user, alcohol is administered almost entirely by mouth. Although injection o f
alcohol is not unheard of, it is rare and extremely dangerous. Some individuals may also
inhale alcohol fumes as a means to getting “high.”
Alcohol is completely absorbed into the bloodstream by the gastrointestinal tract.
The rate of absorption is dependent on several variables, including: whether or not the
individual has eaten, the size o f the individual, and the volume o f fluid in which the
alcohol is taken. Approximately 20 percent o f consumed alcohol is absorbed by the
stomach. The other 80 percent is absorbed rapidly in the upper intestine (Julien, 1988).
Unlike cocaine, which is a stimulant, alcohol is a depressant and behaves similarly
to sedative-hypnotic medications (i.e., benzodiazepines and barbiturates). While cocaine
use inhibits the reuptake of neurotransmitters in the synaptic cleft, alcohol is thought to
prevent the release o f neurotransmitters into the synaptic cleft By preventing the release
o f these transmitters, alcohol depresses numerous bodily and cognitive functions.
The psychological effects o f alcohol are also similar to those o f the sedative-
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hypnotics. Low doses o f alcohol may have a varying effect which is dependent upon the
individual's current mental state and the setting. For example, in some settings moderate
alcohol use may result in euphoria or relaxation, while use in another setting
or at another time may result in anger, rage, hostility, o r social withdrawal- However, as
the dosage increases, the psychological effects become more pronounced. Alcohol use can
also contribute significantly to the development o f mood and affective disorders (Julien,
1988).
The cognitive effects o f alcohol use include disorientation, impaired insight and
judgement, blackout, and diminished intellectual capabilities. Chronic alcohol use may
irreversibly destroy neurons in the brain, producing the permanent dementia referred to
as Korsakoff's syndrome.
Alcohol also results in numerous physical changes. Alcohol use dilates the blood
vessels and long-term use is associated with diseases o f the heart, possibly leading to heart
failure. The use o f alcohol can also produce irreversible changes in the structure and
function of the liver, increasing the amount o f fatty tissue and resulting in a condition
known as cirrhosis. Seventy-five percent o f all deaths attributed to alcoholism are due
to cirrhosis of the liver (Julien, 1988). Chronic alcohol use is also likely to increase the
risk of developing cancer in the mouth, throat, and liver. When used with tobacco, the
risk of cancer is greatly increased.
When alcohol is consumed with other depressant or sedative-hypnotic medications
the effects are additive and can be quite dangerous. This is a concern because minor
tranquilizers, such as Valium or Xanax, are often combined with alcohol use, as is the use
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of marijuana.
A primary distinction between alcohol and cocaine use can be drawn at the level
o f physical dependence. While both drugs result in physical dependence, the withdrawal
syndrome associated with each is different. While withdrawal from cocaine is typically
characterized by mental anguish, depression, intense craving, and sleep disturbance, there
are few physical withdrawal symptoms. Withdrawal from chronic alcohol use, however,
can result in a period o f rebound hyperexcitability that may lead to convulsions, and
ultimately, to death. Tremulousness, hallucinations, psychomotor agitation, confusion,
disorientation, and sleep difficulty are also common during alcohol withdrawal, and are
collectively described as delirium tremens.

Comparing Cocaine and Alcohol Dependence

There are two primary distinctions drawn between cocaine and alcohol. First, at
a physiological level, cocaine acts as a central nervous system (CNS) stimulant, whereas
alcohol acts as a central nervous system (CNS) depressant. Second, cocaine is an illegal
substance, whereas alcohol is legal. This distinction carries with it strong social
implications. For example, the use o f cocaine is more likely to be viewed as socially
deviant and unacceptable, whereas the opinion regarding alcohol use is quite different
(Washton & Stone-Washton, 1990).

Because o f the illegality o f cocaine, covert and

illegal behaviors are required in order to obtain the substance.
Use o f the drug itself, be it cocaine or alcohol, carries with it certain expectations
regarding the outcome of use. It has long been understood that one’s expectations o f a
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drug's effect will affect one’s subjective experience.

Jones (1971), for example,

demonstrated that individuals who smoked marijuana cigarettes with little or no
tetrahydrocannabinol (THC, the psychoactive ingredient in marijuana) claimed to feel
“high” when they thought they were smoking THC containing marijuana.
One’s experience o f drug use can also be greatly affected by the location wherein
drugs are used. While alcohol is often associated with social occasions, bars, or drinking
at home, cocaine use, especially crack cocaine use, is associated with a very different
environment Crack is typically used in what are referred to as “crack houses,” a house
where customers come to purchase and use crack. Post and Weiss (1988) demonstrated,
in rats, that if chug administration occurred in the presence o f other cues or stimuli that
these cues or stimuli could be conditioned to evoke some o f the responses associated with
drug use in the absence o f the drug itself. Findings such as this indicate that the setting
in which a chug has typically been used may come to serve as a significant drug relapse
trigger.
Increased craving is common, for both alcohol and cocaine users, in response to
feelings, places or people that have been associated with previous use. However, there
appears to be much stronger conditioning o f exteroceptive cues associated with cocaine
use than with alcohol use. In fact, the rapidity and strength o f conditioning with cocaineuse stimuli is of greater magnitude than that o f any other substance (Washton & StoneWashton, 1990). People, environments, emotions, behavior, and experience may become
cues which motivate cocaine use to a greater extent than occurs with alcohol. This fact
may have a direct impact on treatment and recovery from cocaine dependence. Because
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stimulus conditions are so strongly associated with cocaine use, they may have a more
significant impact on relapse rates for the cocaine user than they would for individuals
using other drugs. For this reason, the altering o f the cocaine dependent individuals’
environment is crucial to prevent relapse.
Given this information, it is easy to understand the importance many treatment
providers have placed on residential treatment, wherein the individual is removed from
his or her typical environment. It is ironic that research supports the strong impact the
environment has upon relapse to cocaine, yet it has not shown that residential treatment
results in a superior outcome.
When compared to alcohol, cocaine has been found to be more reinforcing to the
user. For example, it has been found that animals can be taught to engage in certain
behaviors (e.g., pressing a lever) to receive cocaine. These animals will continue to work
for the drug even when greater work is necessary to obtain it (Weiss, Mirin, and Bartel,
1994). While it is true that animals will also work for alcohol, their response to cocaine

is much stronger. Weiss, Mirin and Bartel (1994) point out that the response to cocaine
in animal studies is “dramatic and unparalleled” (p. 90). To affirm this statement they cite
research that demonstrates that, under conditions o f unlimited access to intravenous
cocaine, rhesus monkeys continue to work for cocaine and self-administer the drug until
it causes death. This phenomenon does not occur when alcohol is used as a reinforcer.
The withdrawal process also differs for cocaine and alcohol dependent individuals.
Cocaine does not result in the severe withdrawal symptoms, medical symptoms, and
mortality rates that are seen in alcohol dependence; therefore, detoxification does not
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require intensive medical monitoring o r medication (Washton, 1997). The physical
improvement o f cocaine addicts is also much more rapid than that seen in withdrawal
from alcohol. For this reason, motivation to remain in treatment may decrease more
rapidly for the cocaine dependent individual than it would for the alcoholic, who would
require a much longer period o f time to reach a state o f improved physical health
(Washton & Stone-Washton, 1990).
The absence o f severe medical and/or withdrawal conditions may also make
cocaine dependent individuals more likely to be admitted for less intensive services. The
initial treatment o f the cocaine user may focus primarily on cognitive distortions,
dysfunctional behavior patterns, motivation, and relapse prevention, as opposed to the
early focus on managing physical withdrawal for the alcohol dependent individual.
When compared with the long history o f treatment outcome research for alcohol
dependence, the treatment o f cocaine dependence remains in its infancy (Carroll, 1996).
Given the differences between cocaine and alcohol dependence discussed above it is
possible that the outcome o f treatment for alcohol dependent individuals could not be
applied to individuals who are cocaine dependent. For this reason it is important that
treatment modalities are investigated at the level o f both cocaine and alcohol dependence.

Minimal Investigation o f Intensive Outpatient Treatment

Intensive outpatient treatment (IOP), as described by Campbell, Gabrielli, Laster,
and Laskow (1997) “provides frequent contact with patients, psychoeducational
programming similar to inpatient treatment, and management o f relapse issues in the
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realistic outpatient setting” (p. 16). Washton (1997) started perhaps the first substance
dependence intensive outpatient program in the nation in 1982 with a program for cocaine
dependence. According to Washton, the “cocaine epidemic” that emerged during the
1980s was a primary factor in the evolution o f intensive outpatient services. A t that time,
Washton states, treatment providers were prepared to deal only with the treatment of
heroin and alcohol dependence. Unlike heroin and alcohol abusers, cocaine abusers
required no pharmacologic withdrawal or medication and often showed no serious
medical problems. Additionally, evidence had begun to suggest strongly by the mid1980s that inpatient care was no more effective than outpatient treatment, especially when
cost was taken into account (Cummings, 1991). For these reasons IOP treatment became
an acceptable treatment option.
Initially IOP was not a recognized modality and third party payers would not
reimburse for the service. In the fifteen-year interim, however:
IOP has become an important treatment modality and a widely accepted level o f
care . . . It is considered a treatment o f choice for many substance dependent
patients and its popularity continues to grow as clinicians seem to believe in its
helpfulness (Gotheil, 1997, p. xvi).
Washton (1997) points out that IOP has become a treatment of first choice for
managed care and other third-party payers. However, despite the popularity o f IOP, it
is not always an appropriate level of treatment (Washton, 1997). Due to the limited
amount of research investigating IOP treatment, it is difficult to identify patients who do
benefit from IOP or whether, in fact, any patients benefit from it (Gotheil, 1997; Washton,
1997). Three available studies which have investigated IOP treatment are discussed

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

below.
Harrison et al. (1988) conducted the first, and one o f the only, comparison studies
investigating IOP and inpatient treatment. Although the authors did not label this
treatment “intensive outpatient” they did describe it as involving 20 evening sessions
lasting three hours each, which is consistent with what is now considered IOP placement.
The authors compared outcome at six months for 319 alcohol users treated at this level
o f care, as well as at the inpatient level o f care, and found no significant differences.
Campbell, Gabrielli, Laster and Liskow (1997) investigated the efficacy o f IOP
treatm ent for crack cocaine. The authors found that the subjects participating in IOP
demonstrated significant improvement on the composite scales o f the Addiction Severity
Index (ASI; McLellan et al., 1980) at six month follow-up. This study investigated only
the efficacy of IOP treatment and did not compare IOP placement to other levels o f care.
Weinstein, Gottheil, and Sterling (1997) conducted a five year randomized,
controlled study comparing IOP with individual counseling and individual counseling plus
one group treatment session per week. Results indicated improvement for all treatment
groups, with those individuals remaining in treatment longest showing greater
improvement However, the authors found no significant outcome differences between
the treatment groups, nor did they contrast IOP with more intensive levels o f care.
Unfortunately, the studies discussed above represent the first studies o f IOP, either
IOP alone, or comparisons o f IOP and other treatment modalities (Gottheil, 1997). In
1991 Cummings pointed out that the efficacy of IOP treatment had yet to be tested. By
1997, little had changed and Gottheil stated the urgent need for many more research
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comparisons o f different IOP programs with other treatment modalities. “At present,”
states Gottheil, “IOP is well established clinically, but the research story remains to be
told” (p. xviii).

Summary

Substance abuse and dependence continue to be significant problems in this
country. The immense cost o f controlling, and treating drug use, coupled with the
profound impact o f drug use on health care costs, make explicit the need for effective
treatment and prevention.

In an era dominated by managed care, however, the

importance o f determining the most appropriate treatment at the least possible cost is
made all the more urgent.
Research findings over the past decade indicate that residential/inpatient treatment,
while being the most expensive, may not be more effective than less intensive and less
costly day treatment These findings, combined with the impact o f managed care, have
greatly changed the field of substance dependence treatment However, as length of stay
continues to become abbreviated, research must be provided to support the effectiveness
o f currently accepted treatment levels.
Research to date has focused primarily on comparing residential treatment to
partial day hospitilization, neglecting the currently prevalent intensive outpatient level of
care. As the use o f IOP becomes more prevalent, as it undoubtedly will, the need for
outcome data contrasting this modality with more, and less, intensive modalities will be
greatly needed.
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In addition to the limited amount o f research investigating IOP treatment, there
are other areas o f substance dependence treatment which require further investigation.
First, existing treatment outcome research has typically used the length o f stay considered
“standard” at the time o f the study. For this reason, the majority o f research has
investigated 28 day or longer residential programs. This is currently a length o f stay
which is likely to be unacceptable, in all but the most severe cases, by private insurance
or sources o f public funding. For this reason, the treatment outcome literature must be
persistently “updated” in order to keep pace with length o f stay restrictions.
A further concern involves the populations investigated. There is not a great deal
of treatment outcome research contrasting outcome o f alcohol and cocaine dependent
subjects. Typically research has focused primarily on either one population or the other.
Additionally, the majority o f treatment research in this area has been conducted at VA or
University Medical Centers. These centers often investigate a fairly homogeneous group
of participants, for example exclusively veteran.

Research is also needed which

investigates independent, publicly-funded treatment centers.
This study compared treatment outcome for alcohol and cocaine dependent
participants treated at the level o f residential or intensive outpatient treatment. The
residential length o f stay utilized in this study was 10 days. Additionally, the population
investigated in this study was more diverse with regard to diagnosis, ethnicity, and gender
than were the populations investigated in previous published studies in this area.
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Purpose and Hypotheses

The primary purpose o f this study was to evaluate differences in outcome for
substance dependent participants placed in residential and intensive outpatient treatment
following a 10 day treatment protocol. It has been found in other research that there is
“no overall advantage for residential over non-residential settings” (Miller & Hester,
1986, p. 794). However, there has been little investigation o f the impact o f IOP
placement in relation to residential treatment.

There have also been few studies

investigating outcome differences between alcohol dependent subjects and those
dependent on cocaine. Additionally, this study utilized a currently standard length o f stay.
Treatment outcome in this study was measured by self-report and assessed 8 areas
related to recovery from substance dependence: (1) medical status, (2) employment
status, (3) drug/alcohol use, (4) psychiatric status, (5) denial, (6) AA or NA attendance,
(7) relapse prevention strategies, and (8) social support system.
The primary hypothesis o f this study was that there would be no significant
difference for alcohol or cocaine dependent participants at any level o f care on measures
o f drug/alcohol use, employment status, denial, 12 step participation, relapse prevention,
medical status, psychiatric status, or social support. In effect, it was hypothesized that
general treatment outcome is not affected by treatment level.
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METHOD

Experimental Design

This study used a 2 X 2 between-groups design to examine differences in outcome
for alcohol and cocaine dependent participants placed in residential and intensive
outpatient treatment following a 10 day treatment protocol. Treatment outcome was
again evaluated at 30 and 60 days after beginning treatment.

Participants

Participants included 48 chemically dependent clients receiving treatment at
Gateway Recovery Services between the months o f May 1998 and September 1998.
Participants were referred from a number o f sources, including therapists outside o f
Gateway Recovery Services, medical centers, Central Diagnostic Referral Agencies
(CDRs), primary care physicians and from the judicial system. Prior to consenting to
participate in this study, all participants were assigned to one o f two treatment levels by
an intake specialist; the treatment levels were residential treatment or intensive outpatient
treatment (IOP).
Following treatment placement, 48 participants were randomly selected from a
total pool o f 132 clients who met criteria to participate in this study. At intake, or

28
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discharge from detoxification, participants were asked to sign an informed consent form
(See Appendix A) and to complete an intake evaluation (See Appendix B).

In the event

that a client was currently intoxicated by alcohol, as determined by blood alcohol content
(BAC) and/or had used drugs within the past 24 hours, completion o f the informed
consent form and evaluation was delayed until after detoxification.
Only subjects meeting criteria for alcohol or cocaine dependence as their primary
Axis 1 condition participated in this study. Evaluation by an intake specialist and a
treatment provider were utilized in an effort to exclude clients with other primary Axis
I diagnoses.

Materials and Apparatus

The study was conducted at Gateway Recovery Services, a residential and
outpatient center specializing in the treatment o f addictive disorders. The treatment
approach at Gateway Recovery Services is based upon the Minnesota Model, also
referred to as the Minneapolis Model which draws heavily from the guiding principles o f
Alcoholics Anonymous. AlcohoL, cocaine and other substance dependent clients are
treated together in the program, although different treatment focuses may be emphasized
for different addictions. Treatment focuses on overcoming denial, fostering participation
in Alcoholics and/or Narcotics Anonymous (AA/NA), and providing information about
the process o f addiction and cues to relapse. The program consists o f individual therapy,
daily group therapy, and daily education sessions. For the purposes o f this study,
treatment was provided by five certified addiction counselors (CAC-I).
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Measures o f emotional problems, treatment acceptance, relapse potential, and
suitability of the recovery environment were arrived at by using criteria specified by the
American Society o f Addiction Medicine (ASAM) Patient Placement Criteria for
Substance-Related Disorders, Second Edition (PPC-2, 1996).
PPC-2 indicators were arrived at through completion o f a questionnaire including
questions designed to specifically address ASAM criteria and through information
gathered by Gateway intake specialists at the time o f treatment intake.
Clients at Gateway Recovery are offered treatment at primarily five levels o f care:
detoxification, residential, day, intensive outpatient, and outpatient treatment. Clients are
offered treatment consistent with their need as determined by ASAM criteria (1996).
However, it is typical that insurance providers will not reimburse the client at a level
consistent with the recommended level o f care. For this reason, many clients will elect
to be placed at a less intensive level o f care which will be more fully reimbursed by their
insurance provider. For example, based upon ASAM criteria a clinical decision may be
made that the client requires residential treatment However, the insurance provider will
reimburse only at a level which makes intensive outpatient treatment an affordable option
for the client. The client will typically then choose IOP as an alternative to the more
costly residential treatment. This type o f placement allows for investigation o f clients
exhibiting similar needs for service, but receiving different levels o f care. Clients may also
elect to receive a less intensive level o f treatment in order to minimize conflicts with
work, school, or family due to time commitments. This is a common motivating factor
for participation in IOP.
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This study investigated treatment at two levels o f care: residential and intensive
outpatient. Residential treatment (ASAM Level U L l) provides services staffed by
addiction treatment personnel providing a planned regimen o f patient care in a 24 hour
live-in setting. Intensive outpatient treatment (ASAM Level II. I) provides nine or more
hours of structured programming per week; individuals at this treatment level attend three
hours o f structured programming at least three times weekly. Additional distinctions
between these levels o f care are as follows: residential treatment involves 24 hour care,
mandated AA/NA attendance, structured physical activities, acupuncture and additional
didactic presentations not available at the IOP level.

Measures

Independent Variables

This study utilized two independent variables: Axis I diagnosis and treatment
group. Axis I diagnosis for participants in this study was either cocaine dependence or
alcohol dependence as defined by the Diagnostic and Statistical Manual o f M ental

D isorders - Fourth Edition (DSM-IV * American Psychiatric Association, 1994).
Diagnosis was arrived at based upon examination and interview by an intake specialist,
evaluation by the primary treatment provider, and chart review by the primary researcher.
Participants were assigned to either residential or intensive outpatient (IOP) treatment
groups.
Participants were not randomly assigned to treatment groups. Harrison, Hoffman,
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Gibbs, Hollister and Luxenberg (1988) discuss the “concerns and pragmatic realities that
became insurmountable barriers to a random assignment design” (p. 362) in discussing
their examination o f treatment outcome. A number o f obstacles made random assignment
to treatment group difficult in this study. Foremost among these was a refusal by
diagnostic and referral agencies, as well as clinical staff, to consider outpatient treatment
as a viable option for those participants meeting ASAM criteria for residential treatment
who have a source o f funding for such treatment In other words, if a patient had a
funding source that would reimburse for residential treatment and the patient met ASAM
criteria for residential treatment, treatment providers were not willing to place them in
IOP treatment as a part.of randomization.
This study was designed primarily in order to study the effectiveness o f differing
levels o f treatment. The study was not designed to show the efficacy o f these various
treatment levels. In order to conduct the research at the clinical site, it was necessary to
sacrifice the control one would have in conducting an efficacy study and has resulted in
no random assignment. In an attempt to provide some randomization, participants were
randomly selected from an available pool o f 132 clients.

Dependent Variables

Demographic Information

Demographic data were gathered by the intake worker through the completion o f
the Center for Substance Abuse Services Data System (see Appendix C). This is a form
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which is completed for all participants in treatment at Gateway Recovery Services. Data
relevant to the current study were reported, including: age, age at first drug or alcohol
use, arrest history, drug o f choice, education, employment, ethnicity, gender, current
income, insurance provider, legal involvement, previous treatment attempts, attendance
at AA or NA, and marital status. Ail participants were informed that this data would be
used for the purposes o f this study.

Intake. Ten Dav. Thirty Dav. and Sixty Dav Evaluations

The evaluations utilized in this study (see Appendices B, D, and E) address three
of the six problem areas classified in the ASAM criteria: treatment acceptance/resistance,
relapse potential, and recovery environment. The questionnaires were devised by the
authors in consultation with five certified addictions counselors.

Questions were

submitted by the authors to the counselors and the measures were refined to reflect the
recommendations o f the treatment providers. The finalized questionnaires were agreed
to reflect the essential criteria to assess each o f the areas under investigation by all five
counselors and the authors. The questionnaires also include questions from four subscales
of the Addiction Severity Index (Medical, Drug/Alcohol Use, Psychiatric Status and
Employment Status) as constructed by McLellan et al. (ASI, 1980).
The ASI is composed o f both interviewer severity ratings and composite scores.
The interviewer rating items have not been included in the evaluations used in this study,
but items necessary to obtain composite scores for the subscales used have been included.
The ASI composite score is based upon the sum o f several o f the individual information
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questions within each o f the subscales. Each composite is adjusted for the answer range
o f each item and for the total number o f items in the composite. This is accomplished
through mathematical steps (see Appendix G). Composite scores for each o f the other
areas under investigation were arrived at utilizing a similar method (see Appendix H).
Evidence for the reliability and validity o f the ASI has been presented in numerous
publications (Alterman et al., 1994; Alterman et al., 1998; Kosten et al., 1983; McLellan
et al., 1980, 1985).

Intake Questionnaire. The intake evaluation (see Appendix B) is a 40 item
questionnaire which addresses the following areas:
1. Medical status (Questions 1-6) - 6 questions
2. Employment status (Questions 38-40) - 3 questions
3. Drug/alcohol use (Questions 7-13) - 7 questions
4. Psychiatric status (Questions 18-27) - 10 questions
5. Denial (Questions 14-17) - 4 questions
6. Participation in AA or NA (Questions 28-29, 35) - 3 questions
7. Relapse prevention strategies (Questions 30-34) - 5 questions
8. Social support system (Questions 36-37) - 2 questions

Ten Day Follow-up. The intake assessment has been modified to evaluate
outcome at 10 days (See Appendix D). The 10 day follow-up assessment consists o f 30
questions and addresses the following areas:
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1. Medical status (Questions 1-5) - 5 questions
2. Drug/alcohol use (Question 24) - 1 question
3. Psychiatric status (Questions 18-19) - 2 questions
4. Denial (Questions 6-11) - 6 questions
5. Participation in AA or N A (Questions 13, 17, 22, 30) - 4 questions
6. Relapse prevention strategies (Questions 14-16, 20-21) - 5 questions
7. Social support system (Questions 12, 23) - 2 questions
8. General treatment acceptance (Questions 25-29) - 5 questions

Thirty and Sixty Dav Follow-up. The intake assessment has also been modified
in order to assess outcome at 30 and 60 days (See Appendix E). The follow-up
assessment consists o f 43 questions and addresses the following areas:
1. Medical status (Questions 1-5) - 5 questions
2. Employment status (Questions 40-42) - 3 questions
3. Drug/alcohol use (Questions 6-12, 37-38, plus use chart) - 8 questions
4. Psychiatric status (Questions 17-26) - 10 questions
5. Denial (Questions 13-16) - 4 questions
6. Participation in AA or N A (Questions 27, 29, 35, 39) - 4 questions
7. Relapse prevention strategies (Questions 30-34) - 5 questions
8. Social support system (Questions 28, 36) - 2 questions
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Procedure

Participants were asked to complete the informed consent form and intake
evaluation at the time o f intake. Following intake, treatment was provided by one o f
five certified addictions counselors (CAC-I) at the level o f residential or IOP placement.
The treatment protocol implemented in this study did not differ from that used on a daily
basis at Gateway Recovery Services.
*

The treatment program consists o f daily group therapy, daily education sessions
(including both videos and lectures) focusing on the biopsychosocial aspects of
addiction, the 12 steps, relapse prevention, and weekly individual counseling.
Residential clients participate in all activities on a daily basis, as well as being required
to attend nightly AA and N A meetings.

Clients in IOP treatment attend 3 hours of

treatment per day for at least 9 hours per week, typically 12 hours per week. IOP clients
attend primarily didactic presentations and group therapy, with AA/NA attendance
highly recommended (see Table 1).
All participants were evaluated with the 10 day outcome assessment at the
completion o f 10 days o f treatment; this includes 10 days o f residential treatment or 10
treatment days of IOP treatment. A “treatment day” would be a day within which the
subject participated in structured treatment at Gateway; therefore, days when the subject
was not at Gateway (e.g., a weekend) would be excluded. Subjects were re-evaluated
again at 30 days and once more at 60 days, following the 10 day follow-up.
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Table 1
Comparing Service at Different Treatment Levels
Treatment Level
Service

IOP

Residential

Hours per day

24

Hours per week

Variable

9 o r more

AA/NA Participation

Required

Recommended

Acupuncture

Offered

N ot offered

Relaxation Therapy

Offered

Not offered

Didactic Session

Required

Required

Group Treatment

Required

Required

Individual Treatment

Required (once weekly or
as needed)

Required (once
weekly)

Relapse Prevention Group

Required

Recommended

Initial and 10 day follow-up evaluations were completed on-site at Gateway
Recovery. In order to gather follow-up data at 30 and 60 days, the treatment outcome
assessment was mailed to all participants at approximately 20 and 50 days after
completion of the 10 day assessment.

The participant was provided with a self-

addressed stamped envelope in order to return the assessment. Participants were also
informed that upon receiving the completed assessment they would be mailed a gift
certificate good at a local business.
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Human Subjects Protection

All information collected from participants has been treated in accordance with
the ethical standards o f the American Psychological Association (APA, 1982, 1992).
Data were collected and are being stored in a confidential manner. Additionally,
informed consent for participants was obtained (see Appendix A ). Results are reported
in a group format so that no individual can be identified.
There were no direct benefits to the participants beyond that which they would
receive from participating in treatment at Gateway Recovery Services. However, they
were informed o f the contribution that their participation makes to ensuring the most
effective treatment for future recipients.
The primary potential risk for participants was the added duress o f completing
the assessment on four separate occasions. However, they were informed that they could
terminate participation at any time without penalty.
Only Human Subjects Institutional Review Board approved methods were
implemented throughout the course o f the study (See Appendix F).
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RESULTS

Results are presented in six main sections. First, descriptive data related to
demographic characteristics and intake data, as well as analyses between groups on
demographic data and intake data are presented. Second, participants who completed 30
day and 60 day assessments are compared with participants who did not. Third, groups
are compared on dependent measures at 10 day, 30 day, and 60 day assessments. Fourth,
overall relapse levels at 10 day, 30 day, and 60 day assessments are discussed. Fifth,
participants who participated in aftercare are compared with those participants who did
not. Finally, the overall cost o f treatment is discussed. An alpha level of .05 was used for
all statistical analyses.

Baseline Data

Baseline data are available from two sources. First, basic demographic data are
available for 47 of the 48 participants in the study. Second, baseline measures are
available from the intake assessment on all 48 participants.

Demographic Characteristics

Demographic data were available for 47 o f the 48 total participants and are
summarized in Table 2.

39
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Table 2
____________________________ Demographic Data__________________________
___________________Total

Alcohol Participants
IOP
Res
___________________(N=47) (N=12)
(N-12)
Variables

Cocaine Participants ANOVA
IOP
Res
(N=ll)
(N=12)_______ F

AA/NA attend (%
attending)

36.2%

35%

22%

46%

36%

ns

Age (years)

34.5

34.3

35.1

33.6

35.5

ns

Age at first use
(years)

20.5

17.4

19.3

21

25

.07

Gender (% male)

66

85.7

66.7

46.2

63.6

ns

Arrests 6 mos (#
times)

.49

.5

.33

.46

.63

ns

Arrests 5 years (#
times)

L76 ’

2.14

1.33

1

2.5

ns

Education (yrs)

12.04

11.6

12.5

11.7

12.45

ns

Ethnicity (%white)

72.3%

92.9

88.9

53.8

54.5

ns

Employment (%fixll- 29.8
time)

42.9

11.1

23.1

36.4

ns

Income (yr)

10727

12996

10000

9048

10420

ns

Insurance (%public
fund)

57.4

42.9

55.6

61.5

72.7

ns

Marital (%currently - 31.9
married )

35.7

33.3

30.8

27.3

ns

Days used in past 30

10.4

6.7

14.6

9.15

13.27

ns

Public Asst (%
receiving)

12.8

14.3

0

30.8

0

.08

Previous treatment
(% having received)

23%

21%

11%

30%

27%

ns
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The mean age o f all participants was 34.5 years, with a range from 18 to 51 years.
The majority o f participants were Caucasian (72.3%); 25.5% were African-American.
Sixty-six percent (66%) o f participants were male; 34% were female. Slightly more than
half of the participants (53.2%) had completed high school or received their GED; 23.4%
had quit school prior to graduating and 23.4% o f participants had some education beyond
high school. Only 4.3% o f participants were currently enrolled in higher education.
Thirty-two percent (31.9%) o f participants were married; 21.3% were divorced.
Thirty percent (29.8%) o f participants were currently employed full-time; 14.9%
were working part-time; and just over fifty percent o f participants (51.1%) were
unemployed. The mean salary was $10,727 per year, modal salary was $1000 per year.
The majority o f participants’ treatment funding was provided by public funding (57.4%);
only 14.9% had their own insurance. Thirteen percent (12.8%) o f participants were
currently homeless.
The mean age of first drug or alcohol use was 20.5 years. The mean number o f
days drugs or alcohol had been used in the past thirty was 10.4. Forty-three percent o f
participants (42.6%) had a history o f abusing a secondary drug, in addition to their
primary drug o f abuse. These secondary drugs were overwhelmingly alcohol (23.4%) and
marijuana (12.8%). Six percent (6.4%) o f participants had a history o f injecting drugs.
A little over one-third o f participants (36.2%) had attended a 12-step recovery group
within the previous thirty days. Twenty-three percent (23.4%) o f participants had been
treated previously for chemical dependence.
Thirty-two percent (31.9%) o f participants had been arrested once in the past six
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months; 8.5% had been arrested twice in the past six months. O f those participants
charged with an alcohol or drug related crime (N=12) in the previous six months, 66.6%
were charged with driving under the influence (DUI), 33.3% with possession or sale o f
an illegal substance.
Thirty-two percent (31.9%) o f participants had been arrested once in the past five
years; 10.6% twice in the past five years; and 17% three times in the past five years.
Twenty-five percent (25.5%) o f participants had received a DUI in the past five years;
19.1% had been charged with possession or sale o f an illegal substance over the previous
five years; 4.2% had been charged with this crime more than once in the previous five
years. Thirty-percent (29.8%) o f participants were currently on probation; 10.6% were
on parole; 17% were placed in a diversion program; and 6.4% were awaiting sentencing.
A one-way analysis o f variance was used to compare the residential/alcohol,
IOP/alcohol, residential/cocaine, and lOP/cocaine groups on demographic data. Analysis
resulted in no significant differences in demographic characteristics among the four
groups. However, a trend toward significance was noted on the variable o f age at first
drug use, E (3,44) = 2.51, p=.07. Post-hoc analyses using a Tukey test reveal that the
residential/cocaine group started using drugs at a significantly later age than did the other
groups (age 25), with the IOP/alcohol group starting at the youngest age (age 17).

Intake Assessment

A ll 48 participants completed the intake assessment. A one-way analysis o f
variance was used to compare data from the intake assessment across groups on the
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following variables: alcohol use, drug use, medical status, psychiatric status, employment
status, denial, participation in AA/NA, relapse prevention, and social support Significant
between group differences were found only for the following variables: use of alcohol, E
(3, 45) = 9.72, p= 001, and use o f drugs, E (3, 45) = 10.6, p=.001. Post-hoc analysis
using a Tukey test reveal that the residential/alcohol group had a significantly greater
problem with alcohol use than did the IOP/alcohol, IOP/cocaine, and residential/cocaine
groups. Post-hoc analysis also indicates that the residential/cocaine group had a greater
problem with drug use than did the residential/alcohol group and the IOP/alcohol group;
however, the difference between residential/cocaine and IOP/cocaine was not significant.
The IOP/cocaine group had a significantly greater problem with drug use than did the
IOP/alcohol group.

Completers Versus Non-completers

All o f the participants completed the initial 10 day treatment protocol and the
intake and 10 day assessment. Two-thirds (66.7%) o f the overall sample (N = 32)
completed the 30 day follow-up assessment and 41.7% o f the overall sample (N = 20)
completed the 60-day follow-up. Thus, the attrition rate for the 30-day follow-up was
33.3% and for the 60 day follow up it was 58.3%.

Descriptive Measures for Completers Versus Non-completers

At 30 day follow-up, data were provided by 32 participants; 16 participants did
not provide follow-up data. Multiple ANOVAs were conducted to assess for the
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possibility o f differences between completers and non-completers at 30 day follow-up.
Analysis revealed no significant differences between participants who completed the 30
day follow-up and those who did not on the following variables: age, age o f first use, use
o f denial, education, employment status, marital status, history o f previous treatment,
sex, and arrest history.
At 60 day follow-up, data were provided by 20 participants; 28 participants did
not provide follow-up data. As at 30 day follow-up, multiple ANOVAs were conducted
to assess for the differences between completers and non-completers. Analysis revealed
no significant differences between participants who completed the 60 day follow-up and
those who did not on the following variables: age, age o f first use, use o f denial,
education, employment status, marital status, history o f previous treatment, sex, and
arrest history.
These results on completion versus non-completion held true when multiple
logistic regression analyses were conducted. Additionally, treatment intensity (i.e.,
residential or intensive outpatient) was not found to be predictive o f completion o r non
completion using a logistic regression analysis.
Overall, the inpatient group was no more likely than the IOP group to complete
either the 30-day (66.7% completion for both groups) or the 60-day (41.7% completion
for both groups) follow-up assessment The alcohol dependent group was slightly more
likely to complete the 30-day follow-up than was the cocaine dependent group, though
this difference is not statistically significant (70.8% vs. 62.5% completion) There was
no difference between the cocaine and alcohol dependent groups completion rate for the
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45
60-day follow-up (41.47% for both groups).

Follow-up

Mean composite scores on the scales o f alcohol use, drug use, medical status,
psychiatric status, employment status, denial, relapse prevention, participation in AA/NA,
social support and current level o f step completion at intake, 10 day, 30 day, and 60 day
assessments for the cocaine dependent and alcohol dependent groups are presented in
Tables 3 and 4. Tables 5, 6, and 7 show the improvement in mean composite scores
between intake and 10 days, 30 days, and 60 days, respectively.

Ten-dav Follow-up

Ten day assessment data were available for all participants. Data comparing
intake and 10 day follow-up on the scales o f alcohol use, drug use, medical status,
psychiatric status, denial, relapse prevention skills, participation in AA/NA, and social
support were analyzed using multiple repeated measures ANOVAs (see Table 5).
Significant improvement from baseline to ten day follow-up was evident for all groups in
the areas o f alcohol.use, E (1, 45) = 13.79, p = .001; drug use, E (1, 45) = 33.60, p =

.001; denial, E (1,45) = 5.67, p = .004; relapse prevention, E (1, 45) = 59.86, p = .001;
and participation in AA/NA, E (1,45) = 15.61, p = .001. Significant improvement was
not evident for medical status, psychiatric status, or available social support.
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Table 3
Mean Composite Scores for Cocaine Dependent Participants at Intake, 10 Day, 30
Day, and 60 Day Assessment

Intake

Scale

10 Day

30 Day

60 Day

Res

IOP

Res

IOP

Res

IOP

Res

IOP

ASI-Alc

.24

.12

.21

.12

.15

.04

.11

0

ASI-Drug

.52

.41

.31

.29

.17

.12

.12

.15

ASI-Med

.20

.34

.20

.30

.23

.22

.22

.32

ASI-Psy

.35

.25

.24

.20

.28

.15

.15

.20

ASI-Emp

.65

.60

n/a

n/a

.50

.60

.46

.71

Accept

.16

.15

.06

.10

.05

.20

.07

.23

Denial

.17

.17

.05

.14

.04

.15

.05

.18

RlpsPrev

.54

.37

.29

.24

.41

.33

.41

.41

AA/NA

.74

.64

.54

.65

.27

.61

.43

.69

Soc Suppt

.14

.16

.21

.22

.23

.26

.30

.18

Step

0

0

2.3

2.4

2.6

2

3.2

3

Differential group improvement (interaction effects) was evident for several
variables. All groups showed very modest improvement in alcohol use (including the
IOP/alcohol group), except the residential/alcohol group, which showed significant
improvement, E (3, 45) = 7.57, j t = .001. While all groups showed some improvement
in chug use, the IOP/alcohol group did not, E (3, 45) = 7.42,

.001. Interestingly, all

groups showed some improvement in psychiatric status, barring the residential/alcohol
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group whose ASI score was worse at 10 day follow-up, E (3, 45) = 3.75, £ = .017. Ia
the area of relapse prevention skills, all groups showed significant improvement, except
for the IOP/alcohol group which did not, E (3, 45) = 3.58, £ = .021. Finally, all groups
showed significant improvement in AA attendance except the IOP/cocaine group which
showed very modest improvement, F (3,45) = 3.01, £ = .039.

Table 4
Mean Composite Scores for Alcohol Dependent Participants at Intake, 10 Day, 30
Day, and 60 Day Assessment

_____________Intake_______10 Day______ 30 Day______ 60 Day________________
Scale

Res

IOP

Res

IOP

Res

IOP

Res

IOP

ASI-Alc

.58

.33

.38

.31

.14

.20

.07

.16

ASI-Drug

.28

.09

.15

.12

.03

.04

.02

.05

ASI-Med

.35

.23

.43

.23

.32

.12

.17

,04

ASI-Psy

.37

.27

.52

.23

.26

.05

.22

.03

ASI-Emp

.58

.72

n/a

n/a

.49

.37

.41

.79

Accept

.10

.32

.11

.27

A6

.43

.17

.35

Denial

.12

.33

.11

.29

.12

.46

.18

.50

RlpsPrev

.45

.37

.18

.28

.28

.35

.23

.40

AA/NA

.83

.66

.51

.56

.36

.60

.65

.78

Soc Suppt

.14

.10

.12

.16

.16

.28

.17

.23

Step

0

0

2.4

2.6

1.8

1.4

2.4

.8
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Table 5
Mean Improvement in Composite Scores From Intake to 10 Day Follow-Up,
___________ Repeated Measures ANO VA____________________
Mean Change
Res/Coke Res/AIc

Scale

Mean Change
IOP/Coke IOP/Alc

F

F-Interaction

ASI-Alc

.03

20*

0

.02

.001

.000

ASI-Drg

.21

.13

.12

-.03*.

.000

.000

ASI-Med

0

-.08

.04

0

ns

ns

ASI-Psy

.11

-.15*

.05

.04

ns

.017

ASI-Emp

n/a

n/a

n/a

n/a

n/a

n/a

Denial

.12

.01

.03

.04

.004

ns

RlpsPrev

.25

.27

.13

.09*

.000

.021

AA/NA

.20

.32

.01*

.10

.000

.039

-.07
-.06
ns
Soc Suppt
-.01
.02
^Indicates group contributing to significant interaction effect.

ns

Thirtv-Dav Follow-up

Thirty-day follow-up assessment data were available for 32 participants. Data
comparing intake, 10 day follow-up, and 30-day follow-up on scales o f alcohol use, drug
use, medical status, psychiatric status, employment status, denial, relapse prevention,
participation in AA/NA, social support, and completion o f the 12 steps o f AA were
analyzed using multiple repeated measures ANOVAs (see Table 6).

Significant

improvement from baseline to thirty day follow-up was evident for all groups for the
following variables: alcohol use, F (2, 56) = 15.27, £ = .001, drug use, F (2, 56) = 30.11,
£ < .001, psychiatric status, F (2, 56) = 7.28, £ = .002, employment status, F (1, 28) =
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4.80, p = .037, relapse prevention skills, E (2, 56) = 15.23, p = .001, and participation in
AA/NA, E (2, 56) = 11.75, p = .001. Significant improvement was not evident for
medical status, denial, social support, and completion o f the 12 steps.

Table 6
Mean Improvement in Composite Scores From Intake to 30 Day Follow-Up,
________________________Repeated Measures ANOVA________________________
Mean Change
Res/Coke Res/AIc

Scale

Mean Change
IOP/Coke IOP/Alc

F

F-Interaction

AS I-Ale

.10

.50*

.08

.094

.000

.001

ASI-Drg

.30

.18

.25

.08*

.000

.073**

ASI-Med

.02

.08

.08

.0

ns

ns

ASI-Psy

.12

.14

0*

.17

.002

.002

ASI-Emp

.23

.12

.04

-.02

.037

ns

Denial

.06

.04

.04

0

ns

ns

RlpsPrev

.15

.18

.03

.03

.000

ns

AA/NA

.47

.47

.03*

.06*

.000

.026

-.20
-.06
ns
Soc Suppt
-.02
0
^Indicates group contributing to significant interaction effect.
**Indicates trend toward significance.

ns

Interaction effects were apparent for three variables: alcohol use, psychiatric
status, and participation in AA/NA. Additionally, a trend was apparent for an interaction
effect for drug use.

In the area o f alcohol use, while all groups showed some

improvement, the residential/alcohol group showed significantly greater improvement than
any other group, E (6, 56) = 4.25, p = .001. Psychiatric status improved for all groups
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except the IOP/cocaine group, which showed no improvement, E (6, 56) = 4.09, £ =
.002. Both o f the residential treatment groups (residential/cocaine and residential/alcohol)
had significantly greater participation than did either o f the IOP groups (IOP/cocaine and
IOP/alcohol; E (6, 56) = 4.09, p = .026). For drug use, all groups showed significant
improvement, barring the IOP/alcohol group, which showed only a modest improvement,
resulting in a trend toward significance, E (6, 56) = 2.06, p = .073.

Table 7
Mean Improvement in Composite Scores From Intake to 60 Day Follow-Up,
________________________ Repeated Measures ANOVA________________________
Mean Change
Mean Change
Res/Coke Res/AIc IOP/Coke IOP/Alc

Scale

F

F-Interaction

AS I-Ale

.04

.65*

.11

.04

.028

.005

ASI-Drg

.28

.07

.19

.11

.000

ns

ASI-Med

.03

.10

.09

.07

ns

ns

ASI-Psy

.23*

.09

.01

.24*

.001

.011

ASI-Emp

.23

.13

.04

-.01

.033

ns

Denial

.04

.03

.02

-.05

ns

ns

RlpsPrev

.10

.22

-.10

0

.011

ns

AA/NA

36

.12

-.12

-.03

.001

ns

-.18
.02
-.11
ns
Soc Suppt
.16
*Indicates group contributing to significant interaction effect.

ns

Sixtv-Day Follow-up

Sixty-day follow-up assessment data were available for 20 participants. Data
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comparing intake, 10 day follow-up, 30-day follow-up, and 60-day follow-up on the
scales o f alcohol use, drug use, medical status, psychiatric status, employment status,
denial, relapse prevention, participation in AA/NA, social support, and completion o f the
12 steps of AA were analyzed using multiple repeated measures ANOVAs (see Table 7).
Significant improvement from baseline to sixty-day follow-up was evident for all groups
for the following variables: alcohol use, E (3, 48) = 11.78, p. = .028, drug use, E (3,48)
= 15.72, p = .001; psychiatric status, E (3, 48) = 6.18, p = .001; employment, E (2,32)
= 3.81, p = .033; relapse prevention skills, E (3, 48) = 4.16, p = .011; and participation
in AA/NA, F (3,48) = 6.61, p_= .001. Significant improvement was not evident for the
following variables: medical status, denial, and social support.

Interaction effects

were apparent in two areas: alcohol use and psychiatric status. The residential/alcohol
group showed significantly greater improvement than did any other group, E (9, 48) =
4.57, p = .005. The residential/cocaine and IOP/alcohol groups showed significantly more
improvement in psychiatric status than did the residential/alcohol and IOP/cocaine groups,
E (9, 48) = 2:75, p =.011.

Overall Abstinence

Chi-square analyses were used to compare residential and intensive outpatient
groups in terms o f total abstinence from alcohol and drugs since treatment. The residential
group had a statistically significant higher rate o f total abstinence (91.7%) than the IOP
group (41.7%) at 10 days, x2(1, N = 48) = 8.42, p = .003, but the difference at 30 days
and 60 days was no longer statistically significant (see Table 8).
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Table 8
Percent o f Participants Having Relapsed at Each Follow-Up

Group

N*

10 Day

N*

30 Day N*

60 Day

Res/Cocaine

12

8.3

8

33.3

5

8.3

Res/Alcohol

12

8.3

8

16.7

5

16.7

IOP/Cocaine

12

50

7

41.7

5

33.3

IOP/Alcohol

12

50

9

35.7

5

21.4

50
38.5
20
26.9
48
32
Total
* Total sample size for each group at each follow-up point

These results on total abstinence held true when multiple logistic regression
analyses were conducted to control for intake level o f drug and alcohol use and
subsequent treatment At 10 days, as treatment intensity decreased (i.e., from residential
to IOP), the likelihood o f relapse increased, -2LL = 49.8, p = .0041. However, treatment
intensity was no longer predictive o f relapse at 30 o r 60-day follow-up.
Chi-square analyses were also used to compare groups by diagnosis on total
abstinence from alcohol and drugs since treatment There were no statistically significant
differences in relapse rate between alcohol dependent and cocaine dependent groups at
any follow-up period (see Table 9). Multiple logistic regression analyses also indicated
that diagnosis was not predictive o f relapse at 10, 30 o r 60 days.
When groups were analyzed with a logistic regression as a whole (i.e., regardless
o f diagnosis or level of placement) the following information was revealed. At 10 days,
no variables were predictive o f relapse except denial, with higher composite scores on

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

denial predicting higher levels o f relapse, -2LL = 55.28, £ = .024. At 30 days, attendance
at AA or NA was predictive o f relapse with less attendance predicting higher relapse rates
-2LL = 26.34, p = .000; other variables were not predictive. Finally, at 60 days, no
variables were predictive o f relapse.

Table 9
Percentage o f Cocaine and Alcohol Dependent Participants Having Relapsed
at Each Follow Up Point
Follow Up

Cocaine Dependent

Alcohol Dependent

(% relapsed) N

(% relapsed) N

Chi Square
X2

R

10 Day

29.2

12

30.8

12

.015

ns

30 Day

37.5

15

26.9

17

1.12

ns

60 Day

20.8

10

19.2

10

.000

ns

Aftercare Participation

For the following discussion, outpatient treatment is defined as involving
individual counseling with participation in up to one formal group per week. Table 10
shows the percentage of participants from the residential and IOP groups engaged in
aftercare at 30 and 60 days. Half o f the residential group (54.2%) completing the 30-day
follow-up assessment participated in outpatient treatment following their residential
treatment. Only 27% of the IOP group participated in outpatient treatment following
their IOP treatment Chi-square analysis revealed that this difference is not statistically
significant Logistic regression analysis also revealed that treatment intensity is not
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predictive of participation in aftercare at 30 days.

Table 10
Percentage o f Residential and IOP Participants Participating in Aftercare at 30 and 60
Day Follow-Up

30 Days
Total
OP

IOP

60 Days
Total OP

IOP

ANOVA
F

Residential

54.2

37.5

16.7

16.7

16.7

0

ns

IOP

26.9

23.1

3.8

15.4

15.4

0

ns

Approximately seventeen percent (16.7%) o f the residential group completing the
60-day follow-up assessment continued to be involved in outpatient counseling. Fifteen
percent of the IOP group continued to be involved in outpatient counseling at 60 days.
Chi-square analysis reveals that this difference is not statistically significant. Logistic
regression analysis also indicates that treatment intensity is not predictive o f participation
in aftercare at 60 days.
Examination at the level o f diagnosis reveals that o f those participants with a
diagnosis o f cocaine dependence who completed the 30-day evaluation, 41.7% were
attending outpatient counseling following their initial treatment For alcohol dependent
participants, 45.8% reported outpatient counseling at 30 days. This difference is not
statistically significant when analyzed with a chi-square analysis. Logistic regression
analysis also reveals that diagnosis is not predictive o f participation in after care at 30
days.
At 60-day follow-up, 20.8% of cocaine dependent participants reported ongoing
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outpatient counseling, while 16.7% o f alcohol dependent participants reported
participation in outpatient counseling. Again, these differences are not statistically
significant when analyzed using a chi-square analysis. Logistic regression analysis also
reveals that diagnosis is not predictive o f participation in after care at 60 days.
Finally, logistic regression analysis revealed a trend toward significance when
examining participation in aftercare at 30 days as an overall predictor o f relapse at 30
days, regardless of treatment group -2LL = 4, p=.078. At 30 days, as participation in
aftercare decreased, the likelihood o f relapse increased. However, logistic regression
examining participation in aftercare at 60 days as an overall predictor o f relapse at 60 days
was not significant and revealed no trend toward significance.

Comparing the Cost o f Treatment

The cost of a day o f residential treatment at the facility at which this study was
conducted was $380.00, whereas a day o f IOP treatment was $130.00. Thus, 10 days o f
residential treatment totals $3800.00, compared to $1300.00 for 10 days o f IOP
treatment. These totals can be assumed for all participants. However, overall aftercare
increases the cost of treatment. A residential client who continues to be engaged in IOP
treatment at 30 days averages a cost o f $4970.00; a residential client who continues to
be engaged in outpatient treatment would average approximately $4320.00. In contrast,
an IOP client who continues to be engaged in IOP at 30 days would average a cost of
approximately $2470.00; an IOP client who continues to be enaged in outpatient
treatment would average approximately $1820.00. At 60 days, the cost o f a residential
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client who continues to be involved in IOP treatment increases to $6530.00; in outpatient
to $4840.00. The IOP client who remains involved in IOP treatment at 60 days has
amassed an average cost o f $3030.00, in outpatient $2340.00.
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DISCUSSION

The discussion is presented in 5 main sections. First, a brief summary o f the
findings o f this study are discussed. Second, broad treatment effects and an evaluation
o f the primary hypothesis are addressed. Third, the results and method o f the current
study are compared with those o f published research. Fourth, the implications o f the
current findings are discussed. Finally, benefits, limitations and future directions o f the
research are explored.

Summary

The purpose o f this study was to investigate the effectiveness o f treatment for
alcohol and cocaine dependence at the residential and intensive outpatient levels o f
treatment.

Additionally, the study was designed to compare effectiveness o f the

residential and intensive outpatient levels o f treatments for an alcohol dependent group
and a cocaine dependent group. Overall, the results o f this study indicate that both
residential and IOP treatments are effective in treating alcohol and cocaine dependence.
During the course o f the study both residential and IOP participants, regardless o f
diagnosis, showed comparable improvement in use o f drugs, denial, relapse prevention
skills and employment status. Further, the results support the use o f IOP treatment as a
viable alternative to residential treatment for alcohol dependent and cocaine dependent
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patients at a cost of roughly one-third that o f residential placement.

Broad Treatment Effects

Despite the fact that random selection was used in this study, rather than random
assignment, there were no significant differences between groups on any demographic
measure. Additionally, data analysis of intake data revealed only that alcohol dependent
participants entering residential treatment had an initially greater problem with alcohol
than did alcohol dependent participants entering IOP treatment.
Participants in both the residential and intensive outpatient treatment groups,
regardless o f diagnosis, achieved highly significant reductions in ASI composite scores
at 10 day, 30 day, and 60 day follow-up. Improvement in problem areas demonstrate that
both residential and IOP treatment are effective.
Immediately following 10 days o f treatment, individuals in all groups showed
improvement in the areas o f participation in AA/NA, alcohol use, drug use, denial, and
relapse prevention. However, at 10 days significant improvement was not evident for
medical status, psychiatric status, and available social support. The lack o f improvement
in these areas is not entirely surprising. W ith regard to medical status and psychiatric
status, neither o f these areas serve as a primary treatment focus in chemical dependence
treatment Additionally, ten days is a short period o f time to expect great improvement
in such significant areas. This can also be said o f social support. Social support is
typically something that is built up over time, typically in settings outside o f treatment,
and is unlikely to manifest itself after only ten days o f treatment.
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At ten days after beginning treatment, the residential/alcohol group showed
significantly more improvement in alcohol use than did any other group, including the
IOP/alcohol group, a finding which persisted at 30 day and 60 day follow-up. The greater
improvement may be directly attributable to the fact that the residential/alcohol group had
a greater problem with alcohol to begin with and, therefore, possessed the capacity for
greater improvement.
Additionally at the 10 day assessment the residential/alcohol group showed a
worsening o f psychiatric symptoms. One would assume that all groups experienced
similar psychological distress related to their abstinence and it is unclear as to why the
residential/alcohol group would have greater distress.
The IOP/alcohol group failed to demonstrate significant improvement at the 10day assessment on the relapse prevention skills variable. Relapse prevention skills are
thought to enable the individual to effectively cope with triggers and urges in order to
avoid relapse. Despite the failure o f the IOP/alcohol group to demonstrate improvement
in this area, later follow-up did not indicate greater relapse rates for the IOP/alcohol
group.
The IOP/cocaine group failed to show improvement in AA/NA attendance at 10
days. Failure to participate in AA or NA has also been thought to be a predictor o f
relapse. However, again, later analyses do not indicate greater relapse rates for the
IOP/cocaine group.
Additionally at 10 days it was found that the residential groups had significantly
higher abstinence rates than did the IOP groups. While this is a significant difference, it
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is not a surprising one. I f one considers the nature o f residential treatment, wherein the
treatment recipient is in the treatment setting 24 hours a day, it becomes obvious that
opportunities for drug o r alcohol use are limited. However, in the IOP setting one is in
his or her typical environment for 21 hours per day, and in treatment only three, and then
only approximately 3 times per week, thus vastly increasing the opportunity for relapse.
Perhaps the more important finding is that these differences in total abstinence rate no
longer held true at the 30 day and 60 day assessments which indicates that, at least 60
days after treatment, abstinence rates do not differ regardless o f treatment level.
At the 30 day assessment, significant improvement continued to be present in the
areas o f participation in AA/NA, alcohol use, drug use, and relapse prevention skills.
Additionally, psychiatric and employment status showed improvement at this assessment
point. Significant improvement was not found in the areas o f medical status, denial, social
support, and completion o f the Twelve Steps.
Psychiatric status does demonstrate improvement at 30 day follow-up, which may
be associated with the increased stability o f abstinent life, in contrast to the turmoil
associated with addiction.
Failure to show significant improvement in completion of the Twelve Steps o f
AA/NA is also not surprising in that these programs encourage the participant to “work”
the steps in a slow and thorough manner. Thus, an individual begins at Step One and
slowly progresses through the twelve steps.
The failure o f social support to demonstrate improvement at both 30 and 60 days
is troubling in that relapse has long been considered to increase when individuals lack a
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supportive environment- This issue will be discussed further below.
At sixty day follow-up, significant improvement remains present in the areas o f
participation in AA/NA, alcohol use, drug use, psychiatric status, employment status, and
relapse prevention. Medical status, denial and social support fail to show improvement
at this assessment as well.
The lack o f improvement in denial and social support at 60 days is disconcerting.
As has been previously mentioned, it has long been an assumption in the field of chemical
dependence treatment that lack o f a supportive environment and denial o f an existing
problem contribute to relapse. The finding that, with treatment, these variables do not
improve at 60 days increases the need for research investigating longer periods of followup.
Many would argue that the true measure o f treatment success is abstinence. While
abstinence cannot be the only measure o f improvement, it certainly is an important one.
An average of thirty percent (29.8%) o f participants in this study had relapsed at 10 day
follow-up. By thirty-day follow-up, approximately thirty-two (31.9%) percent o f the
participants completing the follow up had relapsed. Finally, at sixty-day follow up, nearly
twenty percent (19.7%) of those completing the assessment had relapsed.
O f course, common sense dictates that more than thirty-two and twenty percent
o f participants had relapsed at thirty and sixty days, respectively. It would be absurd to
assume that none o f those individuals failing to respond to the follow up had relapsed.
In fact, it is much more likely that these non-completers did, in fact, relapse. If the worst
case scenario is considered, wherein all non-responders had relapsed, the relapse rate at
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30 days becomes 64.2% and at 60 days 78%. Admittedly this is an unscientific analysis
and is certainly a conservative estimate in favor of relapse. However, the results are likely
more representative o f relapse rates than those available in this study. These are
disheartening statistics with regard to chemical dependence treatment in general, however
they do not alter the fact that relapse rates were not significantly different between IOP
and residential groups. While chemical dependence treatment in general may be less than
25% effective, it may still be the case that IOP treatment is ju st as effective, and
unfortunately ineffective, as residential treatment.
It is important that when considering the effectiveness o f treatment one does not
limit consideration to relapse alone. While relapse may be the ultimate measure, the other
variables investigated in this study are very important in their own right. As McLellan et
al. (1997) state “even those patients who show abstinence from substance use following
treatment - but continue to have unresolved employment, family, and/or psychiatric
problems - are at significant risk for early relapse” (p. 81).
The primary hypothesis o f this study was that there would be no significant
differences for alcohol or cocaine dependent participants at any level o f care on measures
o f drug/alcohol use, employment status, denial, 12 step participation, relapse prevention,
medical status, psychiatric status, or social support. Although the residential/alcohol
group demonstrated significantly more improvement in alcohol use over the course o f the
study, this is thought to be related to the fact that they had a significantly greater problem
with alcohol to begin with. This is the only area in which one group showed consistent
differential improvement across the three follow-up evaluations.
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Integration o f Findings With Existing Literature

Convergent Findings

This study investigated both cocaine and alcohol dependence.

As results

demonstrated no significant differences between these two groups on outcome, they will
be discussed as a whole in comparison with previous research. It is important to
recognize, however, that some o f the studies discussed below addressed cocaine or
alcohol dependence exclusively.
The results o f the current study are consistent with previously published research
in a number o f areas. This study demonstrated significant improvement in outcome
measures at both the residential (Alterman & McLellan, 1993; Longabaugh et al.,
1983;Schneider, Mittelmeier, & Gaddish, 1996) and IOP treatment levels (Campbell et
al., 1997; McLellan et al., 1997).
The effectiveness o f IOP as a general treatment modality has been previously
demonstrated (Campbell et al., 1997). Campbell et al. (1997) pointed out the need for
effectiveness studies comparing IOP with inpatient treatment in order to determine
whether or not more improvement occurs for individuals placed in inpatient treatment
than does for individuals placed in IOP treatment. The results o f the present study
indicate that this does not occur, at least at the level of residential placement.
Literature review revealed only one other published study comparing IOP
treatment with residential treatment for chemical dependence. That study, authored by
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Harrison et al. (1988), did not define this level o f treatment as “IOP”, but did describe it
as involving 20 sessions of three hours each, which is consistent with IOP treatment. The
results o f the current study are consistent with the findings o f Harrison et al. in revealing
no significant difference in outcome between more and less intensive treatment settings.
The current study is also consistent with the findings o f previous studies
investigating IOP versus inpatient treatment for psychiatric conditions (Creed et al., 1990;
Kiesler & Sibulkin, 1987) in finding that IOP is just as successful with regard to general
treatment outcome as inpatient treatment.
Comparisons between the present study and other studies in the field o f chemical
dependence must be made at the level of day treatment versus inpatient treatment, as that
is all that is currently available. Like previous studies, the results o f this study indicate a
statistically significant higher rate o f abstinence for the residential groups at early followup, which disappeared at later follow-up (Schneider, Mittelmeier, & Gaddish, 1996). This
finding supports the long standing assumption that outpatient treatment leaves patients
more vulnerable to relapse by not removing them from environmental cues and triggers.
However, the fact that relapse rates are not different after 30 and 60 days supports the
concept that patients can benefit from being exposed to environmental cues and learning
to cope with them during early recovery (Schneider, Mittelmeier, & Gaddish, 1996).

Pjygrgeat-Eindipgs
Unlike Campbell, Gabrielli, Laster and Liskow (1997), who investigated the
efficacy o f IOP placement and did not find improvement in the areas o f alcohol use and
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employment status, the current study revealed a significant improvement in both. While
this is an important difference, it is also important to recognize the differences between
the two studies, primarily length o f follow-up. hi the current study, at 60 day assessment,
groups demonstrated a significant improvement in these scales. Campbell et al. followed
up at 6-months and found no improvement. It is certainly possible that if the groups in
this study were followed until 6 months that the significant findings would disappear.
Overall, the present study indicated much less participation in AA or NA at
follow-up than have previous studies (Schneider, Mittelmeier, & Gaddish, 1996). While
research related to the outcome o f participation in these groups is rare, as they are often
unwilling to comply with the strict requirements o f formal outcome research (e.g. access
to participants, identification o f non-completers, accurate diagnosis, follow-up, e tc ...),
it has long been assumed that AA is an effective treatment modality. For example,
Toumier (1979) states that “in an area where documentable recoveries are rare, AA alone
has appeared to succeed'’ (p. 230). With this type o f reputation, participation in AA and
NA may be a very important factor in preventing relapse. For this reason, relapse rates
in this study may have been affected by the diminished participation in AA and NA.
As has previously been discussed, this study did not show significant improvement
in medical status, a finding that is divergent from previous research findings (Alterman et
al., 1994: Campbell et al., 1997; McLellan et al., 1997). One reason that medical status
did not improve may be that, though there are medical problems that will improve with
abstinence, there are also significant chronic medical conditions which are not likely to
improve regardless o f abstinence. Additionally, the number o f responders at 60 days was
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fairly small, with four reporting continued significant medical problems.

Contributions o f Findings to the Literature

A prim ary contribution o f the current study is the availability o f data from a
publicly-funded substance dependence treatment center that is obtained in a naturalistic
manner. By utilizing a method o f non-interference to study the treatment o f a substance
dependent population an opportunity becomes available to “see things as they really are”
in a typical chemical dependence treatment setting. While the lack o f random assignment
can be considered a limitation o f this study, several authors (e.g., Howard et al., 1990,
Taylor et al., 1982) question the extent to which individuals randomly assigned to
chemical dependence treatments are representative o f the “real substance abuser.”
Strohmetz, Alterman, and Walter (1990) suggest that there may be serious limitations to
random assignment in chemical dependence treatment comparisons because those patients
agreeing to randomization may differ from the population o f interest.
Second, the differences between the sample population investigated in this study
and those investigated by previous research are substantial, demonstrating the broad
generalizability o f the findings. For example several studies, especially those focusing on
cocaine dependence, have investigated predominantly African-American male populations
(Alterman, etal., 1994; Campbell, etal., 1997; Gottheil, etal., 1995; McKay etal., 1994).
The sample in the present study was more diverse in terms o f gender and race.
Third, the length o f residential treatment investigated in this study is significantly
shorter than that investigated in previous studies, as much as 18 days shorter for some
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studies (e.g., Alterman and McLellan, 1993; Alterman, et al., 1994; McLachlan & Stein,
1982). Thus, the present data provides an evaluation o f treatment efficacy for a length
o f stay consistent with the contemporary standard.
Additionally, the current study provides data at earlier follow-up periods,
including immediately following treatment, which have not been previously available.
McLellan et al. (1997) point out the need and importance o f follow-up data at both
periods earlier than and later than 6 months. The period immediately following treatment
and the first few months following treatment are not typically thoroughly investigated.
The typical protocol is intake and 6 month follow-up; the availability o f data at 10 days,
30 days and 60 days provides information about time intervals that were previously
unavailable. It may be helpful for future research to follow such a protocol while
extending follow-up to 90 days, 6 months, 9 months, and one year.
Fourth, the current study contributes to the growing number of studies
demonstrating the effectiveness o f IOP treatment (e.g., Campbell et al., 1997; McLellan
et al., 1997). The need for such data becomes increasingly important as the use o f IOP
treatment continues to rise.
Finally, this study represents one of the first investigating IOP treatment outcome
compared with residential treatment outcome. Although there have been numerous
studies investigating day treatment and inpatient treatment (e.g., Alterman & McLellan,
1993; Longabaugh, etal., 1983; McClachlan& Stein, 1981; Schneider, Mittelmeier, &
Gadish, 1996), literature review has revealed only one published study comparing what
appears to be an IOP treatment program with an inpatient program (Harrison et al.,

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

68

1988).

Implications

The number o f studies indicating that inpatient or residential treatment is not
superior to outpatient treatment increases yearly. The current study is one o f few which
indicates that IOP treatment is just as effective, at least as far as 60 days after beginning
treatment, as residential treatment. The implications o f such findings are numerous and
will be discussed at three levels: theoretical, research, and applied implications.

Theoretical Implications

As was previously mentioned, it has long been an assumption in the field o f
chemical dependence treatment that more intensive, and more expensive, treatment was
the most effective. Miller and Hester (1986) summarized the prevailing treatment attitude
at the tim e o f their study using the “3 R’s model” of treatment: remove from society,

repair the problem, and replace in society. They go on to further state that this model
is “outmoded and inadequate” (p. 803). Research data indicate that the model is certainly
outmoded and inadequate at present However, more than a decade later, there are many
who still subscribe to the “3 R ’s model.” Such a theoretical foundation immediately
weakens the viability o f outpatient treatment as an effective treatment alternative.
Numerous studies have now demonstrated that outpatient treatment, albeit often
more intensive day treatment, can be an effective alternative to inpatient or residential
placement. This study has taken these findings a step further and demonstrated the
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effectiveness o f less intensive and less expensive outpatient treatment as an alternative to
residential treatment.
Admittedly, there will always be a place for inpatient chemical dependence
treatment as there are surely individuals who will respond to nothing less. However, the
theoretical underpinnings o f chemical dependence treatment must now begin to shift to
the recognition that not all, possibly not even most, chemically dependent individuals
require inpatient care.
This study also demonstrates that a general treatment approach can prove equally
beneficial to both alcohol and cocaine dependent individuals, despite the distinct
differences between the addiction process in each disorder. While the addiction process
may differ significantly, perhaps the recovery process does not. It is possible that IOP
treatment is not only the most practical treatment setting for cocaine dependence, but also
the most effective for the simple reason that it provides opportunities to encounter relapse
triggers and cues early in recovery. Such a treatment placement could also be effective
for alcohol dependence for the same reason, because, although external stimuli appear to
be more powerful in cocaine dependence, they certainly affect alcohol dependence as well.

Research Implications

The results o f this study indicate the need for further research investigating IOP
treatment in comparison with residential and inpatient care. An important area o f
investigation would be identifying those individuals who require inpatient care and those
who would benefit equally from less intensive approaches. By further refining selection
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criteria and treatment providers’ ability to match to the most appropriate treatment level,
providers can increase confidence that recipients are being provided the most effective
treatment at the least cost.
Additionally, it is important to begin identifying those factors which contribute to
successful treatment outcome. While studies such as this one demonstrate what does not
contribute to such outcome, in this case treatment setting, they fail to demonstrate what
does. Further research investigating participation in aftercare, participation in self-help
groups, social support, and motivation for treatment and the ways that these variables
contribute to treatment outcome would greatly benefit the field o f chemical dependence.
This study demonstrated few differences in outcome between alcohol dependent
and cocaine dependent participants. This is an area requiring further research due to the
increasing number o f individuals entering treatment who are addicted to “crack” cocaine.
Research must answer the question “are there significant differences between alcohol and
cocaine dependent individuals which must be addressed in treatment, or are the addictions
similar enough to allow for a ‘global’ treatment?”

Practical Implications

Alcohol and cocaine dependent participants do improve when placed in residential
care. Personal experience will attest to witnessing individuals improve at near miraculous
rates while being treated at this level. Nonetheless, available data strongly call into
question whether the improvement witnessed in residential or inpatient care requires the
expense accompanying such placement. I f future research supports the findings o f the
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current study, it is likely that more programs will begin offering IOP placement and less
will offer inpatient placement. Undoubtedly this is likely to be one o f the primary
implications o f such research. The change may occur with only modest research support,
given the huge financial difference between the two treatment levels. Such findings are
likely to gather quick support from managed care in an effort to reduce the cost o f
treatment expenditures.
Additionally, such findings could have a significant impact on the availability o f
treatment to uninsured individuals. With a cost o f approximately one-third that o f
residential placement, sources o f public funding would be able to pay for treatment for
three individuals if placed in IOP, as opposed to only one in residential or inpatient
treatment.
Another implication of the present research findings is that perhaps more
individuals will begin considering substance dependence treatment. It is not difficult to
understand the hardship that being removed from work, family and friends for two weeks
to a month can place on a substance dependent individual. Admittedly, such a hardship
is a small price for recovery; however, as any substance dependence treatment provider
can attest, substance dependent individuals are not known for their ability to consider long
term consequences. When effective treatment can be offered to an individual after work,
or on the weekends, allowing him or her to return home to his or her family on a daily
basis, it becomes more acceptable.
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Limitations

This study has several limitations which should be considered when interpreting
the results. First, the lack of random assignment makes this a quasi-experimental design.
The lack o f random assignment occurred for several reasons. A primary reason was
related to the fact that clinic administrators questioned the acceptability of random
assignment to patients and sources o f funding. Greenfield (1989) supports the concept
that ethical constraints and practical difficulties are very real obstacles to randomization
in clinical research. The author goes on to state that “an exclusive reliance on randomized
controlled trials to provide definitive information about effectiveness is not the answer'’
(p. 1142).
Second, a larger sample would strengthen the confidence that an absence o f
differences in outcome between residential and IOP treatment truly exists. Similar
research investigating inpatient and day treatment have typically been conducted at
facilities serving large numbers o f patients as well as having both practical and financial
resources available to gather data on large numbers o f participants. For example,
Alterman and McLellan (1993) conducted a study funded by the National Institute o f
Drug Abuse (NIDA), the National Institute of Alcohol Abuse (NIAA), and the
Department o f Veterans Affairs investigating 215 alcohol and cocaine dependent
participants; Harrison et al. (1988) conducted a state funded project investigating 319
alcohol dependent participants; Longabaugh et al. (1983) conducted a study funded by
Blue Cross Blue Shield and the NIAA o f 174 alcohol dependent participants; and,
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McClachlan and Stein conducted a project funded by the Ontario Ministry o f Health
investigating 100 alcohol dependent participants.
Third, the use o f self report data is also a limitation o f this study. The debate over
the use of self-report data in clinical and substance abuse research is a long one, with no
definitive resolution. However, a number o f studies have confirmed the validity o f selfreport o f substance abuse, especially when such reporting does not lead to negative
consequences (Sobell et al., 1979; Harrel, 1985). The decision to use self-report data in
this study was based on both the evidence supporting the validity o f self-report data and
practical concerns. For example, requiring participants to submit to drug testing at 10
days, 30 days, and 60 days, would likely have significantly decreased the number o f
individuals willing to participate in the study, as well as having a negative impact on
follow-up. Additionally, while misrepresentation may have occurred, there is no reason
to believe that one group was more or less likely to misrepresent than another.
Fourth, the instrumentation utilized in this study has, for the most part, not been
researched and validated completely. It is recommended that future research utilize the
complete Addiction Severity Index, as well as utilizing adjunctive assessments which have
shown utility in addictions research. Some recommended assessment devices include the
Halikas-Crosby Drug Impairment Rating Scale for Cocaine (HALDIRS; Halikas &
Crosby, 1992), the Symptom Checklist - 90 - Revised (SCL-90-R; Derogatis, 1977), and
a brief measure o f life satisfaction, such as that constructed by Neugarten, Havighurst,
and Tobin (1961>.
Additionally, while the instruments used to assess participants at intake, 10 days,
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30 days and 60 days included portions o f the well researched and validated Addiction
Severity Index (McLellan, et al., 1980), other scales were arrived at through consensus
o f the primary authors and five certified addictions counselors. These scales possess face
validity and practical utility, however, they have not been thoroughly researched and
validity and reliability information are not currently available. Further, the scales are
arrived at by computing a composite o f between 2 to 10 questions. Because the number
o f questions for composites is quite small for some scales, overall scores can be
significantly impacted by the response to only one question.
Fifth, residential and IOP treatment are not different kinds o f treatment, rather
they are settings for treatment This study manipulated only one dimension o f treatment
planning for cocaine and alcohol dependent participants, the setting. While this is an
important treatment variable, other variables such as modality and orientation deserve the
attention o f researchers. For example, the treatment approach utilized in this study is
heavily influenced by Twelve Step philosophy and relies upon Alcoholics Anonymous as
a foundation for treatment. Research investigating other treatment approaches (e.g.,
biopsychosocial models, rational recovery, etc...) would be helpful by providing a broader
research base with which to generalize the current findings.
Sixth, the length o f follow-up in this study is short relative to that o f previous
research. Previous research has typically investigated follow-up at 6 months (Campbell
et al., 1997; McKay et al., 1994; Schneider, Mittelmeier, & Gadish, 1996), or, more
rarely, longer (Edwards et al., 1977; McLachlan& Stein, 1982). A general assumption
in the field of chemical dependence treatment is that relapse generally occurs in the first
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6 months o f treatment, a finding which has some research support ( Hubbard & Marsden,
1986; Hunt et al., 1971). McLellan et al. (1997) state that approximately 60% to 80%
o f patients who relapse do so within three to four months after completing treatment. If
this is the case, it is important that future research extend the length o f follow-up
investigated to at least 90 days, preferably to 6 month follow-up.
Finally, the attrition rate at 60 days in this study was higher than most published
research at 58.3%. Studies reporting attrition rate at 3 months, the time frame most
closely related to that investigated in this study, report attrition rates varying from 9
percent to 32.4 percent. In the current study data were available for less than half of the
sample (41.7%) at 60 day follow-up. For this reason, the percentage o f subjects in the
repeated measures ANOVAs and logistic regression analyses was considerably lower at
30 and 60 days due to missing data at the follow-up.
There are several possible explanations for the larger attrition rate occuring in this
study. First, nearly thirteen percent (12.8%) o f the participants in this study were
currently homeless. Due to the lack o f a permanent address, these individuals became
increasingly difficult to locate as time progressed. Second, over fifty percent (51.1%)
o f the participants in this study were unemployed. It is possible that several participants
relocated in an effort to secure employment during the time period following this study.
Third, while this study provided a small financial incentive, a five dollar gift certificate,
published studies typically offer a much larger incentive, typically around twenty dollars.
Finally, a great deal o f the data in the published literature is gathered in Veteran’s
Administration Hospital settings. Typically these are settings to which treatment
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recipients return on a regular basis. Treatment recipients are also more likely to keep the
facility updated with regard to changes in address or phone number. The unitary focus
o f the treatment facility where this study was conducted does not necessitate such
updating o f information. It is unclear how the attrition rates in this study would compare
to those found in unpublished research.
Future research could increase the amount of data available at follow-up in a
number o f ways. For example, by increasing the overall sample size more data will be
available at follow-up even with similar attrition rates. Additionally, and perhaps more
effectively, participants could be provided a stronger incentive for participation at followup points.

Future Directions and Conclusions

The current study provides a good template for future research; however, there
are a number o f ways in which the methods utilized in this study can be improved upon.
Whether the present results o f this study will be sustained in later studies is a matter to
be determined by subsequent research.
The basic hypothesis o f this study, whether or not IOP is as effective, or more
effective, than inpatient treatment is one that requires further study. While this study, and
others like it, may demonstrate that intensity does not determine the effectiveness o f
treatment, it fails to show what specifically does. The field o f chemical dependence would
greatly benefit from a knowledge o f those variables which do determine treatment
efficacy.
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As pressures to contain the cost o f health care increase, managed care
organizations are likely to respond by reducing the intensity and duration o f treatment.
For many treatment providers this has been a disheartening and discouraging process.
Perhaps, though, a part o f the silver lining in this trend is to reveal those areas where
treatment can successfully be reduced in intensity and duration and still provide effective
results. Research to date has indicated that inpatient substance dependence is such an
area o f treatment. If intensive outpatient treatment is demonstrated to be an effective
alternative to inpatient placement, there really are no losers, barring perhaps for-profit
treatment agencies. Insurance providers will benefit from decreased costs, treatment
agencies can provide more services to a larger number o f individuals, and patients are
more likely to self-initiate treatment when it is less intrusive.
Finally, perhaps by identifying low cost effective treatment we may begin to swing
the pendulum from enforcement o f drug policy to treatment Since about 1970, American
politics have focused on the “hard side” o f thug policy, enforcement and placed the “soft
side”, treatment and education, on the back burner (Baum, 1996).
The irony o f current drug policy is perhaps captured best in a passage o f Dan
Baum ’s 1996 book, Smoke and Mirrors. In the passage Baum discusses William
Bennett’s (the drug czar during the Bush Administration) highly publicized attitude
toward drugs. Bennett describes drugs as possessing the capacity to enslave and take
away the ability o f individuals to function as free citizens. A sentiment shared by many
and one which may truly be accurate. However, the irony comes about when one
considers that during the same era those individuals who fell into the “slavery o f
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addiction” were prosecuted and imprisoned for making a bad “choice.” Bennett, in
talking with David Tell, his speechwriter, makes the comment that “those who have even
the barest contact with drugs should be punished severely” (p. 272).
The idea that drugs are addictive and disabling indicates that treatment, and not
prosecution, should be the first line o f defense. However, i f such a concept is to be
acceptable to the American public, treatment providers m ust show that the cost of
treatment is lower than the cost o f imprisonment. Additionally, it must be shown that the
long-term benefits associated with treatment are more beneficial to society than those
which result from prosecution and incarceration.
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College of Arts and Sciences
Department of Psychology

W E S T E R N M IC H IG A N UNIVERSITY

Principal Investigator Malcolm H. Robertson, Ph.D.
Research Associate:
Shawn E. Charmed, MA, TLf.P
I have been asked to participate in a research project investigating the outcome o f substance abuse treatment at different
levels o f care at Gateway Recovery Services. I understand that these data will be used by Gateway Recovery Services
in order to implement the most appropriate standards o f care for future recipients. I also understand that these data will
be used for Shawn Channeil’s dissertation project, entitled “Comparing Outcome o f Residential, Day, and Intensive
Outpatient Treatment Services for Chemical Dependence." Data will be collected between the months o f April, 1998
and September, 1999.
My consent to participate in this project indicates that I will be asked to complete a 40 question assessment at intake, 10
days into treatment, 30 days after beginning treatment and 60 days after beginning treatment. I understand that this
involves completing a questionnaire on 4 occasions. I also understand that the questionnaire will be mailed to me at 30
and 60 days after beginning treatment, with all postage expenses pre-paid by the researcher. Participation will also involve
providing general information about myself including age, gender, history o f drug use, treatment history, employment
history, as well as involvement with the legal system.
f
As in all research, there may b e unforeseen risks to the participant. If an accidental injury occurs, appropriate measures
will be taken; however, no compensation or additional treatment will be made available except as otherwise stated in this
consent form. I understand that completing the questionnaires will be the only impact on the services I receive at
Gateway, my treatment will not be altered in any way by this research, and I will receive the same quality o f care
regardless o f my participation.
I understand that my participation may benefit future treatment' recipients by allowing Gateway to modify treatment
procedures to provide the most appropriate care. I also understand that individuals requiring treatment at other facilities
may be assisted by the outcome o f this research. My participation will also provide me the opportunity to receive S10.00
in gift certificates redeemable at McDonald’s Restaurant o r United Artists Theatres. One SS.OO gift certificates will be
mailed to you upon completion o f the 30 day questionnaire and one at the completion o f the 60 day questionnaire.
I understand that all the information collected from me is confidential. That means that my name will not appear on any
papers on which this information is recorded. The forms will all be coded, and Shawn Channeil will keep a separate
master list with the names o f participants and the corresponding code numbers. Following the completion o f data
collection this master list will be destroyed. All other forms will be retained for three years in a locked file at Gateway
Recovery Services. .
I understand that I may refuse to participate or quit at any time during the study without effect on the services I receive
from Gateway Recovery Services. This means that my treatment at Gateway Recovery Services will not be affected if
I should refuse to participate or withdraw from participation. If I have any questions o r concerns about this study, I may
contact either Malcolm Robertson at 387-8339 o r Shawn Channeil at 382-9820. I may also contact the Chair o f the
Human Subjects Institutional Review Board at Western Michigan University at 387-8293 or the Vice President for
Research at 387-8298 with any concerns that I have. My signature below indicates that I understand the purpose and
requirements o f the study and that I agree to participate.

Signature

Date
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Intake Assessment
Please take the time to read each question in the questionnaire thoroughly. Keep in
mind that some questions require you to fill in the blank, others are yes or no, and
others require you to rate your answer on a scale o f I to 5. On all questions with a
rating (1-5), I is the least and 5 is the most. Answer each question as honestly as
possible and remember that your answers are completely confidential (they will not
be shared with others, including your therapist). Please remember to turn this
questionnaire in to the receptionist when finished.

Section 1 - Medical History
1.
How many times in your life have you been hospitalized for medical problems (do
not include hospitalizations for alcohol or drug problems)?

2.

Do you have any chronic (long-term) medical problems which continue to interfere
with your life?
YES NO

3.

Are you taking any prescribed medication on a regular basis for a physical
problem?
YES NO

4.

How many days have you experienced medical problems in the past 30 days?

5.

How troubled or bothered have you been by these medical problems in the past 30
days?
1
2
3
4
5
Not at All
Slightly
Somewhat
Considerably
Extremely
6.

How important to you now is treatment for these medical problems?
1
2
3
4
5
Not at All
Slightly
Somewhat
Considerably
Extremely
Section 2 - Drug and Alcohol Use
7.
How much would you say you spent during the past 30 days on alcohol?
I ____________

8.

How many times in your life have you been treated for alcohol abuse?
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9.

How bothered have you been in the past 30 days b y alcohol problems?
1
2
3
4
5
Not at All
Slightly
Somewhat
Considerably
Extremely
10.

How important to you now is treatment for these alcohol problems?
1
2
3
4
5
Not at All
Slightly
Somewhat
Considerably
Extremely
11.

How many days in the last 30 have you experienced problems with drug abuse?

12.

How bothered have you been in the past 30 days by drug problems?
1
2
3
4
5
Not at All
Slightly
Somewhat
Considerably
Extremely
13.

How important to you now is treatment for these drug problems?
1
2
3
4
5
Not at All
Slightly
Somewhat
Considerably
Extremely
14.

Do you feel that someone has forced you into treatment?
YES
NO

15.

Do you believe that you are an addict and/or alcoholic?
YES
NO

16.

Do you believe that if you use drugs and/or alcohol you will lose control?
1
2
3
4
5
Strongly Agree
Agree
Undecided
Disagree Strongly Disagree.
17.

Do you believe that it is necessary that you remain abstinent (always clean) from
all mind-altering chemicals?
I
2
3
4
5
Strongly Agree
Agree
Undecided
Disagree Strongly Disagree
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Section 3 - Psychiatric History
Have you had a significant period inyoiir life fa period o f two weeks or greater), that was
not a direct result o f drug or alcohol use, in which you have:
18.

Experienced serious depression that was not a direct result o f drug or alcohol use?
YES NO
In the past 30 days?
YES
NO

19.

Experienced serious anxiety or tension that was not a direct result o f drug or
alcohol use?
YES NO
In the past 30 days?
YES
NO

20.

Heard voices or seen things which were not really there which was not a direct
result o f drug or alcohol use?
YES
NO
In the past 30 days?
YES NO

21.

Had trouble understanding or remembering that was not a direct result o f drug or
alcohol use?
YES
NO
In the past 30 days?
YES NO

22.

Become violent that was not a direct result o f drug or alcohol use?
YES
NO
In the past 30 days?
YES NO

23.

Have you ever, at any time, thought seriously about suicide. Thinking which was
not a direct result o f drug or alcohol use?
YES
NO
In the past 30 days?
YES NO

24.

Have you ever attempted suicide. An attempt that was not a direct result o f drug
or alcohol use?
YES
NO
In the past 30 days?
YES NO
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25.

Have you taken prescribed medications for any psychological or emotional
problem in your life?
YES
NO
In the past 30 days?
YES NO

26.

How many days in the past 30 have you experienced these psychological or
emotional problems?

27.

How much have you been bothered by psychological o r emotional problems in the
last 30 days?
1
2
3
4
5
Not at All
Slightly
Somewhat
Considerably
Extremely
Section 4 - M iscellaneous
28.
How often do you attend AA or NA meetings (circle one).
NEVER
RARELY
ONCE A MONTH ONCE A WEEK

DAIL
Y

Write in number o f times per w eek_________
29.

How many times have you attended AA or NA in the past 30 days?

30.

Do you have persistent cravings for alcohol or other drugs?
1
2
3
4
5
Never
Rarely
Sometimes
A lot o f the time
All the time
31.

Do you believe that you can recognize triggers (things which may make you want
to use drugs and/or alcohol) and cope with urges that threaten your recovery?
1
2
3
4
5
Never
Rarely
Sometimes
A lot o f the time
All the time
32.

Do you believe that you can manage triggers (things which may make you want to
use drugs and/or alcohol) and urges without using drugs and/or alcohol?
1
2
3
4
5
Never
Rarely
Sometimes
A lot of the time
All the time
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Section 4 - Environment
33.
Do you believe that you have skills that allow you to remain abstinent/clean even
when your environment is not supportive o f your recovery?
1
2
3
4
5
Not at All
Rarely
Sometimes A lot o f the time
All the time
34.

Have you been able to stay away from environments and situations where you
might use drugs or alcohol?
1
2
3
4
5
Not at All
RareLy
Sometimes A lot o f the time
All the time
35.

Do you have transportation available so that you can attend AA or NA meetings?
1
2
3
4
5
Never
Rarely
Sometimes A lot o f the time
All the time
36.

Is your home environment supportive o f your recovery?
1
2
3
4
Not at All
Rarely
Sometimes A lot o f the time

5
All the time

37.

Do you have family and/or friends that will help you in recovery?
YES NO

38.

Are you currently working (circle one)?
Full Time
Part Time
Not at All

39.

How many days were you paid for working in the past 30?

40.

How much money did you receive for working (net income)in the past 30 days?
£______________
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10 Day Follow-up
Please take the time to read each question in the questionnaire thoroughly. Keep in
mind that some questions require you to fill in the blank, others are yes or no, and
others require you to rate your answer on a scale o f 1 to 5. On all questions with a
rating (1-5), 1 is the least and 5 is the most. Answer each question as honestly as
possible and remember that your answers are completely confidential (they will not
be shared with others, including your therapist). Please remember to turn this
questionnaire in to the receptionist or the person who gave you the questionnaire
when finished.
Section 1 - Medical Status
1.

Do you have chronic medical problems which continue to interfere with your life?
YES NO

2.

Are you taking any prescribed medication on a regular basis for a physical
problem?
YES NO

3.

How many days have you experienced medical problems in the past 30 days?

4.

How troubled or bothered have you been by these medical problems in the past 30
days?
1
2
3
4
5
Not at All
Slightly
Somewhat Considerably
Extremely
5.

How important to you now is treatment for these medical problems?
1
' 2
3
4
5
Not at All
Slightly
Somewhat Considerably
Extremely
Section 2 - Drug/Alcohol Use
6.

How important to you now is treatment for alcohol problems?
1
2
3
4
5
Not at All
Slightly
Somewhat Considerably
Extremely
7.

How important to you now is treatment for drug problems?
1
2
3
4
5
Not at All
Slightly
Somewhat Considerably
Extremely
8.

Do you feel that someone has forced you into treatment?
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YES
9.

NO

Do you believe that you are an addict and/or alcoholic?
YES
NO

10.

Do you believe that if you use drugs and/or alcohol you will lose control?
1
2
3
4
5
Strongly Agree
Agree
Undecided Disagree
Strongly Disagree
11.

Do you believe that it is necessary that you remain abstinent (always clean) from
all mind-altering chemicals?
1
2
3
4
5
Strongly Agree
Agree
Undecided Disagree
Strongly Disagree
12.

Do you have family and/or friends that will help you in recovery?
YES NO

13.

Do you receive support from AA or NA to help you with your recovery?
YES NO

14.

Do you have persistent cravings for alcohol or other drugs?
1
2
3
4
5
Never
Rarely
Sometimes A lot o f the time
All the time
15.Do you believe that you can recognize triggers (things which may make you want
to use drugs and/or alcohol) and urges that threaten your recovery?
1
2
3
4
5
Never
Rarely
Sometimes A lot o f the time
All the time
16.

Do you believe that you can manage triggers (things which may make you want to
use drugsand/or alcohol) and urges without using drugs and/or alcohol?
1
2
3
4
5
Never
Rarely
Sometimes A lot o f the time
All the time
17.

How many times have you attended AA o r NA in the past 10 days?
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Section 3 - Psychiatric Status
18.

How much have you been bothered by psychological or emotional problems in the

past 10 days?
1
Not at All

2
Slightly

3
Somewhat

4
Considerably

5
Extremely

19.

How important to you now is treatment for psychological problems?
I
2
3
4.
5
Not at All
Slightly
Somewhat
Considerably
Extremely

Section 4 - Environment
20.

Do you believe that you have skills that allow you to remain abstinent even when
your environment is not supportive o f your recovery?
1
2
3
4
5
Not at All
Rarely .
Sometimes A lot of the tim e
All the time
21.

In the past 10 days, have you been able to stay away from environments and
situations where you might use drugs or alcohol?
1
2
3
4
5
Not at All
Rarely
Sometimes
A lot of the tim e
All the time
22.

Do you have transportation available so that you can attend AA or NA meetings?
1
2
3
4
5
Never
Rarely
Sometimes . A lot of the tim e
All the time
23.

Is your home environment supportive o f your recovery?
1
2
3*
4
Not at All
Rarely
Sometimes
A lot o f the tim e
24.

5
All the time

Have you used drugs or alcohol since beginning treatment?
YES
NO

For the following questions, please indicate the level to which you agree with the
statement regarding your treatment at Gateway. Remember that all individual
information is confidential and unknown to your therapist or insurance provider.
25.

Gateway has helped me learn the skills necessary to live a healthy life that is free
from alcohol and drugs.
1
2
3
4
5
Strongly Agree
Agree
Undecided
Disagree
Strongly Disagree
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26.

Group therapy at Gateway helped me with my recovery (Answer only if you had
group therapy at Gateway).
1
2
3
4
5
Strongly Agree
Agree
Undecided
Disagree Strongly Disagree

27.

Individual therapy at Gateway helped me with my recovery (Answer only if you
had individual therapy at Gateway).
1
2
3
4
5
Strongly Agree
Agree
Undecided
Disagree Strongly Disagree

28.

The lectures I attended at Gateway helped me with my recovery (Answer only if
you attended lectures at Gateway).
1
2
3
4
5
Strongly Agree
Agree
Undecided
Disagree Strongly Disagree

29.

Acupuncture at Gateway helped me with my recovery (Answer only if you
received acupuncture at Gateway).
1
2
3
4
5
Strongly Agree
Agree
Undecided
Disagree Strongly Disagree

30.
1

Which of the 12 steps have you completed in your recovery? (Circle steps you
have completed.)
2
3
4
5
6
7
8
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Follow-up
Medical Status
1.

Do you have any chronic medical problems which continue to interfere with your
life?
YES NO

2.

Axe you taking any prescribed medication on a regular basis for a physical
problem?
YES NO

3.

How many days have you experienced medical problems in the past 30?

4.

How troubled or bothered have you been by these medical problems in the past 30
days?
1
2
3
4
5
Not at All
Slightly
Moderately
Considerably
Extremely
5.

How important to you now is treatment for these medical problems?
1
2
3
4
5
Not at All
Slightly
Moderately
Considerably
Extremely
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Drug/Alcohol Use
In the space below please indicate the number o f days, in the past 30, that you have used
alcohol or drugs. Leave space blank if you have not used this substance.
DRUG OR ALCOHOL

PAST 30 DAYS

Alcohol (any at all)
Alcohol (to Intoxication)
Heroin
Methadone
Other opiates
Barbiturates
Sedatives/T ranquilizers
(Valium, Xanax, etc...)
Cocaine
Amphetamines (“Speed)
Marijuana
Hallucinogens (LSD,
Mushrooms, etc—)
Methamphetamine
(“Crank”)
Crack
Inhalants
More than one
substance per day
(includes alcohol)
6.

Which substance is the major problem for you? ____________________

7.

How much would you say you spent during the past 30 days on alcohol?
$ ___________

8.

How bothered have you been in the past 30 days by alcohol problems?
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1
Not at All

2
Slightly

3
Moderately

4
Considerably

5
Extremely

9.

How important to you now is treatment for these alcohol problems?
1
2
3
4
5
Not at All
Slightly
Moderately Considerably
Extremely
10.

How many days in the last 30 have you experienced problems w ith drug abuse?

11.

How bothered have you been in the past 30 days by drug problems?
1
2
3
4
5
Not at All
Slightly
Moderately
Considerably
Extremely
12.

How important to you now is treatment for these drug problems?
1
2
3
4
5
Not at All
Slightly
Moderately
Considerably
Extremely
13.

Do you feel like you have been forced into treatment?
YES
NO

14.

Do you believe that you are an addict and/or alcoholic?
YES
NO

15.

Do you believe that if you use drngs and/or alcohol you will lose control?
1
2
3
4
5
Strongly Agree
Agree
Undecided Disagree
Strongly Disagree
16.

Do you believe that it is necessary that you remain abstinent from all mind-altering
chemicals?
1
2
3
4
5
Strongly Agree
Agree
Undecided Disagree
Strongly Disagree
Psychiatric Status
Within the past 30 days have you:
17.
Experienced serious depression?
YES NO
18.

Experienced serious anxiety or tension?
YES NO

19.

Heard voices or seen things which were not really there?
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YES
20.

NO

Had trouble understanding or remembering?
YES
NO

21.

Become violent?
YES
NO

22.

Thought seriously about suicide?
YES
NO

23.

Attempted suicide?
YES NO

24.

Have you taken prescribed medications for any psychological o r emotional
problem?
In the past 30 days?
YES
NO

25.

How many days in the past 30 have you experienced these psychological or
emotional problems?

26.

How much have you been bothered by psychological or emotional problems in the
last 30 days?
1
2
3
4
5
Not at Ail
Slightly
Moderately
Considerably
Extremely
Specifically Treatment-Related
27.
How often do you attend AA or NA meetings (circle one).
NEVER
RARELY
ONCE A MONTH ONCE A WEEK

28.

Do you have family and/or friends that will help you in recovery?
YES NO

29.

Do you receive support from AA or NA to help you with you recovery?
YES NO

30.

Do you have persistent cravings for alcohol or other drugs?
1
2
3
4
5
Never
Rarely
Sometimes A lot o f the time
All the time
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31.

Do you believe that you can recognize triggers and urges that threaten your
recovery?
1
2
3
4
5
Never
Rarely
Sometimes
A lot o f the time
All the time
32.

Do you believe that you can manage triggers and urges without using drugs and/or
alcohol?
1
2
3
4
5
Never
Rarely
Sometimes
A lot o f the time
All the time
Environment
33.

Do you believe that you have skills that allow you to remain abstinent even when
your environment is not supportive o f your recovery?
1
2
3
4
5
Not at All
Rarely
Sometimes
A lot o f the time All the time
34.

Have you been able to stay away from environments and situations where you
might use drugs or alcohol?
1
2
3
4
5
Not at All
Rarely
Sometimes
A lot of the time
All the time
35.

Do you have transportation available so that you can attend AA or NA meetings?
1
2
3
4
5
Never
Rarely
Sometimes
A lot o f the time
All the time
36.

Is your home environment supportive o f your recovery?
1
2
3
4
Not at All
Rarely
Sometimes
A lot o f the time

5
All the time

3 7.

Have you used drugs or alcohol since beginning treatment?
YES NO

38.

How many times have you used drugs o r alcohol since completing treatment?

39.

Which o f the 12 steps have you completed in your recovery? (Circle steps you
have completed.)
2
3
4
5
6
7
8
9
10
11
12

I
40.

Are you currently working?
Full Tim e
Part Time
Not at All
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41.

How many days were you paid for working in the past 30?

42.

How much money did you receive for working (net income) in the past 30 days?

43.

Have you participated in treatment in the past 30 days (does not include AA o r
NA)?
Yes
No

44.

If you answered “Yes” to Question 43, what type o f treatment have you
participated in (Circle One)?
O utpatient (Individual counseling only, up to one group per week)
Intensive O utpatient (At least three groups for a total o f 9 to 12 hours per week)
Day T reatm ent (At least 4 groups a week for 7 or more hours per day)
Residential/Inpatient T ream ent
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W e s t e r n M ic h ig a n U n iv e r sit y

Date: 13 April 1998
To:

Malcolm Robertson, Principal lavestigatoc^ cJ[
Shawn Channell, Student InvpsugltorT L t • ’

From: Richard Wright, Chair
Re:

HSIRB Project Number 98-03-02

This letter will serve as confirmation that your research project entitled “Comparing Outcome of
Residential, Day and Intensive Outpatient Treatment Services for Chemical Dependency” has
been approved under the full category of review by the Human Subjects Institutional Review
Board. The conditions and duration of this approval are specified in the Policies of Western
Michigan University. You may now begin to implement the research as described in the
application.
Please note that you may only conduct this research exactly in the form it was approved. You
must seek specific board approval for any changes in this project. You must also seek reapproval
if the project extends beyond the termination date noted below. In addition if there are any
unanticipated adverse reactions or unanticipated'events associated with the conduct of this
research, you should immediately suspend the project and contact the Chair o f the HSIRB for
consultation.
The Board wishes you success in the pursuit of your research goals.
Approval Termination:

13 April 1999
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Addiction Severity Index Composite Scores
I.

Intake
1.
Medical: #4/90 + #5/12 +#6/12
2.
Employment: I - (#35/12 + #39/90 + LOG(#40/27))
3.
Psychiatric: #18/10 + #19/10 + #20/10 + #21/10 + #22/10 + #23/10 +
#24/10 + #25/10 + #26/300 + #27/40
4.
Alcohol Use: Demo Data/150 + Demo Data/150 + #9/20 +- #10/120 +
LOG(#7/365)
5.
Drug Use: Demo Data/180 + Demo Data/180 + Demo Data/180 + #12/24
+ #11/80 + #13/24

II.

10 Day
1.
2.
3.
4.

HI.

Medical: #4/8+#5/8
Psychiatric: #18/8 + #19/8
Alcohol Use: Demo Data/90 +Demo Data/90 + #6/12
Drug Use: Demo Data/120 + Demo Data/120 + Demo Data/120 + #7/16

Follow-Up
1.
Medical: #3/90 + #4/12 +#5/12
2.
Employment: 1 - (#3 5/12 + #41/90 + LOG(#42/27))
3.
Alcohol Use: Chart/150 + Chart/150 +#8/20 + #9/20 + LOG(#7/36.5»
4.
Drug Use: Chart/360 (*10) + #10/360 + #11/48 + #12/48
5.
Psychiatric: #17/10 + #18/10 + #19/10 + #20/10 + #21/10 + #22/10 +
#23/10 + #24/10 + #25/300 + #26/140

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Appendix H
Composite Scales Scoring

105

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

General Composite Scores
I.

Intake
1.
2.
3.
4.
5.

Denial: #14/4 + #15/4 + #16/16 + #17/16
Acceptance: #15/3 +- #16/12 + #17/12
AA/NA Attendance: I - (#28/8 + #29/60)
Relapse Prevention: 1 - (#31/16 +- #32/16 +- #33/16 + #34/16)
Social Support: 1 - (#36/8 + #37/2)

II.

10 Day
1.
Denial: #8/4 + #9/4 + #10/16 + #14/16
2.
Acceptance: #10/12 + #9/3 + #11/12
3.
AA/NA Attendance: I - (#17/60 + #13/2)
4.
Relapse Prevention: I - (#15/16 +■#16/16 + #20/16 + #21/16)
5.
Social Support: 1 - (#12/3 +■#13/3 + #23/12)

III.

Follow-Up
1.
Denial: #13/4 + #14/4 + #15/16 + #16/16
2.
Acceptance: #14/3 -f- #15/12 + #16/12
3.
AA/NA Attendance: 1 - (#27/8 + #29/2)
4.
Relapse Prevention: I - (#31/16 + #32/16 + #33/16 + #34/16)
5.
Social Support: 1 - (#28/3 + #29/3 + #36/12)
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